JP3387943B2 - Anticancer drug - Google Patents
Anticancer drugInfo
- Publication number
- JP3387943B2 JP3387943B2 JP23755592A JP23755592A JP3387943B2 JP 3387943 B2 JP3387943 B2 JP 3387943B2 JP 23755592 A JP23755592 A JP 23755592A JP 23755592 A JP23755592 A JP 23755592A JP 3387943 B2 JP3387943 B2 JP 3387943B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- solvent
- chloroform
- reference example
- stirred
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
【発明の詳細な説明】
【0001】
【産業上の利用分野】本発明は、新規なメトトレキセー
ト誘導体、更に詳しくは、制癌剤として有用な新規なメ
トトレキセート誘導体に関する。
【0002】
【従来の技術・発明が解決しようとする課題】メトトレ
キセートは古くより白血病の治療薬として用いられてき
たが、1951年Gubnerらが慢性関節リウマチ
(RA)や乾癬に用いて有効性を報告して以来RAの治
療薬として欧米で使用されてきた。比較的最近になっ
て、用法、用量の詳細な検討が実施され、低用量メトト
レキセート療法が比較的副作用が少なく、しかも優れた
有効性を発揮することが明らかになってきた。しかしメ
トトレキセート服用により生ずる肝障害や肺繊維化等の
副作用も無視できないため、さらに副作用が少なく、か
つ効力の優れた薬物の登場が望まれている。
【0003】これまでに、N10にメチル基以外のアル
キル基が導入されているメトトレキセート誘導体として
は、例えば下記式
【化2】
(J.Med.chem.,22,862(197
9))や式
【化3】
(J.Med.chem.,25,877(198
2))等が知られているが、満足な活性を示すものでは
なかった。
【0004】本発明者らは、この種のメトトレキセート
誘導体において制癌作用面でより優れた化合物を求めて
鋭意研究し、本発明をなすに至った。
【0005】
【課題を解決するための手段】本発明は、下記一般式
(I)
【化4】
式中、R1はCH2、CH2CH2、CH2O、CH2
S、CH2SO、CH2SO2およびCH2NHから成
る群より選ばれた一員を示し;R2は水素原子または炭
素数1乃至4の低級アルキル基を示し;nは1から4ま
での整数を示し;R3は一般式COOR4(ここでR4
は水素原子または炭素数1乃至4の低級アルキル基を示
す)または一般式NHCOR5(ここでR5は置換され
ていてもよいフェニル基を示す)または一般式CONR
6R7(ここでR6は水素原子または炭素数1乃至4の
低級アルキル基を示し;R7は炭素数1乃至4の低級ア
ルキル基または置換されていてもよいフェニル基を示
す)またはPO3H2、SO3Hで表される基を示す;
で示されるメトトレキセート誘導体を提供するものであ
る。
【0006】本発明の化合物は、いずれも文献未載の新
規化合物であり、例えば以下の様にして合成される。
(方法A)
【化5】(方法B)
【化6】(方法C) 一般式(I)におけるR3が、一般式
【化7】
(R′:水素原子または炭素数1乃至4の低級アルキル
基)を示すとき
【化8】 (式中、R1、R2、R3およびnは前記と同じ意味を
示し、R′は水素原子または炭素数1乃至4の低級アル
キル基を示し、A1およびA2は保護基を示し、Xはハ
ロゲン原子を示す。)
【0007】方法Aにおいて、一般式(1)の化合物か
ら一般式(2)の化合物を得る反応は、一般式(1)の
化合物を塩化チオニル、オキサリルクロリド等の酸ハロ
ゲン化剤に懸濁し、触媒量のジメチルホルムアミド等の
共存下、室温で撹拌することにより行う。式中、A1で
示される保護基としては、カルボベンゾキシ基、トシル
基、アセチル基等が挙げられる。
【0008】一般式(2)の化合物と一般式(3)の化
合物から一般式(4)の化合物を得る反応は、一般式
(2)の化合物をジクロロメタン等の溶媒に溶解したも
のを、氷冷下または水冷下で一般式(3)の化合物の水
溶液に加え、炭酸カリウム、水酸化ナトリウム、炭酸水
素ナトリウム等の無機塩基の共存下、室温で撹拌するこ
とにより行う。
【0009】一般式(4)の化合物から一般式(5)の
化合物を得る反応は、アニソールやフェノール等を臭化
水素−酢酸溶液に溶解した溶液に一般式(4)の化合物
を加え、10℃〜60℃好ましくは室温で撹拌すること
により行う。またこの一般式(4)の化合物から一般式
(5)の化合物を得る反応は、一般式(4)の化合物を
メタノールやエタノール、酢酸等の溶媒に溶解させ、パ
ラジウム−炭素を加えた後、水素雰囲気下室温にて撹拌
することにより行ってもよい。
【0010】一般式(6)の化合物と一般式(5)の化
合物から一般式(7)の化合物を得る反応は、一般式
(6)の化合物と一般式(5)の化合物をジメチルアセ
トアミド、ジメチルホルムアミド等の溶媒中、0℃〜1
00℃好ましくは50℃〜60℃で撹拌して行う。特に
R2が水素原子である場合は、さらにメタノールやエタ
ノール等の溶媒に1N−水酸化ナトリウム水溶液を加
え、0℃〜60℃好ましくは35℃で撹拌して目的物を
得る。式中、Xで示されるハロゲン原子としては、臭素
原子、塩素原子等が挙げられる。
【0011】方法Bにおいて、一般式(6)の化合物と
一般式(8)の化合物から一般式(9)の化合物を得る
反応は、一般式(6)の化合物と一般式(8)の化合物
をジメチルアセトアミドやジメチルホルムアミド等の溶
媒中、0℃〜100℃好ましくは55℃で撹拌すること
により行う。
【0012】一般式(9)の化合物と一般式(3)の化
合物から一般式(7)の化合物を得る反応は、一般式
(9)の化合物をジエチルリン酸シアニドや、ジシクロ
ヘキシルカルボジイミドと1−ヒドロキシベンゾトリア
ゾール等の共存下、ジメチルホルムアミド、ジメチルア
セトアミド、N−メチルピロリジノン等の溶媒中撹拌し
た後、一般式(3)の化合物を加え、0℃〜200℃好
ましくは10℃〜80℃で撹拌することにより行う。特
にR2が水素原子である場合は、更にメタノールやエタ
ノール等の溶媒中、1N−水酸化ナトリウム溶液を加
え、0℃〜60℃好ましくは室温で撹拌して目的物を得
る。
【0013】方法Cにおいて、一般式(10)の化合物
と式(11)の化合物から一般式(12)の化合物を得
る反応は、一般式(10)の化合物をクロロホルム、ジ
クロロメタン、テトラヒドロフラン、ジオキサン等の非
プロトン性溶媒に溶解し、式(11)の化合物と水と例
えば炭酸カリウム、トリエチルアミン、炭酸水素ナトリ
ウム、ピリジン等を加え、室温で撹拌することにより行
う。式中、A2で示される保護基としては、カルボベン
ゾキシ基、トシル基、アセチル基等が挙げられる。
【0014】一般式(12)の化合物から一般式(1
3)の化合物を得る反応は、メタノール等の溶媒中、−
60℃〜−20℃好ましくは−30℃で撹拌し、塩化チ
オニルを加えた後、還流することにより行う。
【0015】一般式(13)の化合物から一般式(1
4)の化合物を得る反応は、一般式(13)の化合物を
エタノール、メタノール、テトラヒドロフラン、ジオキ
サン等に溶解し、パラジウム−炭素の共存下、水素雰囲
気下室温で撹拌することにより行う。
【0016】一般式(14)の化合物と一般式(2)の
化合物から一般式(15)の化合物を得る反応は、一般
式(2)の化合物をジクロロメタン等に溶解させ、この
溶解に一般式(14)の化合物と炭酸カリウムまたはト
リエチルアミンと水を加え、室温で撹拌することにより
行うが、混合酸無水物法、活性エステルまたは活性アミ
ド法によりアミド化を行ってもよい。
【0017】一般式(15)の化合物から一般式(1
6)の化合物を得る反応は、一般式(15)の化合物に
あらかじめフェノールまたはアニソールを溶かしておい
た臭化水素−酢酸を加え、室温で撹拌することにより行
う。
【0018】一般式(6)の化合物と一般式(16)の
化合物から一般式(17)の化合物を得る反応は、ジメ
チルアセトアミドおよびジメチルホルムアミドのような
非プロトン性極性溶媒中25℃〜100℃好ましくは5
0℃〜65℃で撹拌した後、例えばトリエチルアミン、
炭酸カリウムまたは炭酸水素ナトリウム等を含む水中で
撹拌することにより行う。
【0019】一般式(17)の化合物から一般式(I)
の化合物を得る反応は、エタノール等の溶媒中、水酸化
ナトリウム溶液を加え、室温で撹拌して行う。
【0020】
【作用】本発明により得られた一般式(I)で示される
化合物は制癌作用を持つ。この作用は、以下に示す実験
例「マウス癌細胞増殖阻害実験」を行うことにより確認
した。
【0021】「マウス癌細胞増殖阻害実験(制癌作
用)」
(方法)
【0022】RPMI1640培地(牛胎児血清を5
%、2−メルカプトエタノールを10−6Mとなるよう
に添加したもの)で浮遊させたマウス リンホイド ネ
オプラスマ P388細胞、あるいはマウスcolon
26カルシノーマ細胞を、平底マイクロプレート(Co
rning社製 #25870)の各ウェルに5×10
3個ずつ入れ、さらに、同じ培地にて作製した薬剤溶液
を入れて、各ウェルが0.2mlとなるようにした。こ
れを炭酸ガス培養装置(炭酸ガス5%,空気95%,湿
度100%)中で3日間培養後、MTT溶液(3−
(4,5−ジメチルチアゾール−2−イル)−2,5−
ジフェニルテトラゾリウムブロミドをリン酸緩衝性生理
的食塩液(pH7.4,10mM)で5mg/mlとな
るように溶解させたもの)を各ウェルに10μlずつ添
加し、さらに4時間培養したのちに培養上清を150μ
lずつ除去して、生成された色素(フォルマザン)をD
MSO(ジメチルスルフォキサイド;150μl/ウェ
ル)で溶解させ、マイクロプレート用分光光度計で吸光
度(540nm)を測定した。
【0023】なお、用いた薬物は下記のものである。
【化9】
【0024】(結果,考察)図1にP388細胞を用い
た場合の例を、図2にcolon26を用いた場合の例
を示した。データは、薬剤を添加していないウェルでの
細胞増殖すなわちその吸光度を100%とし、薬剤を添
加することによって、どの程度までに増殖が抑制された
かを、%で示してある。
【0025】図1および図2から明らかなように、本発
明の化合物は、対照薬より優れた癌細胞増殖阻害作用
(制癌作用)を持つことが確認された。
【0026】
【実施例】
【参考例1】1−カルボベンゾキシ−5−カルボキシインドリンの合
成
【0027】5−カルボキシインドリン(2.0g)と
水酸化ナトリウム(0.6g)を水(20ml)とジエ
チルエーテル(20ml)の混合液に加えた後、氷−水
冷却下、カルボベンゾキシクロリド(2.59g)と水
酸化ナトリウム(2.1g)を加え水(10ml)を交
互に加え、室温下で2時間撹拌した。反応液を2N−塩
酸で酸性にし、析出した結晶を濾過した。エーテルで洗
浄後、風乾することにより目的物(2.8g)を得た。
【0028】1H−NMR(DMSO−d6,δ):
3.10(2H,t,J=8Hz),4.03(2H,
t,J=8Hz),5.23(2H,s),7.2−
8.0(8H,m)
mp;194−196℃
【0029】
【参考例2】N−(1−カルボベンゾキシインドリン−5−カルボニ
ル)−L−グルタミン酸ジエチルの合成
【0030】参考例1.の化合物(2.5g)を塩化チ
オニル(10ml)に懸濁後、触媒量のジメチルホルム
アミドを加え、室温で30分間撹拌した。次いで減圧下
に過剰の塩化チオニルを留去し、残渣をN−ヘキサンで
トリチュレートした。得られた結晶を濾過した後、ジク
ロロメタン(20ml)に溶解し、このジクロロメタン
溶液を氷−水冷下、グルタミン酸ジエチルエステル塩酸
塩(3.0g)とトリエチルアミン(2.8g)を含む
ジクロロメタン(50ml)懸濁液に滴下した。室温で
2.5時間撹拌した後、減圧下に溶媒を留去し、残渣に
氷−水冷却下、酢酸エチル(200ml)と希塩酸(2
00ml)の混合液を加えた。5分間撹拌した後、有機
層を分取した。有機層を5%炭酸ナトリウム水溶液で洗
浄後、硫酸マグネシウムで乾燥した。次いで酢酸エチル
を減圧下に留去し、得られた残渣をシリカゲルカラムク
ロマトグラフィーに付し、溶出溶媒としてクロロホル
ム:メタノール=30:1の混合溶媒を用い、目的物
(3.1g)を得た。
【0031】1H−NMR(CDCl3,δ):1.1
9(3H,t,J=7Hz),1.25(3H,t,J
=7Hz),2.1−2.6(4H,m),3.06
(2H,t,J=8Hz),3.8−4.3(6H,
m),4.75(1H,m),5.20(2H,s),
6.79(1H,d,J=7Hz),7.2−7.7
(8H,m)
mp;120−121℃
【0032】
【参考例3】N−(インドリン−5−カルボニル)−L−グルタミン
酸ジエチルの合成
【0033】参考例2.の化合物(1.8g)をテトラ
ヒドロフラン(80ml)に溶解し、10%パラジウム
−炭素(0.4g)を加えた後、水素雰囲気下、室温で
5時間撹拌した。セライトを用いてパラジウム−炭素を
濾去することにより、目的物(1.2g)を得た。
【0034】1H−NMR(CDCl3,δ):1.2
1(3H,t,J=7Hz),1.29(3H,t,J
=7Hz),2.0−2.6(4H,m),3.00
(2H,t,J=8Hz),3.59(2H,t,J=
8Hz),4.07(2H,q,J=7Hz),4.1
9(2H,q,J=7Hz),4.75(1H,m),
6.47(1H,d,J=9Hz),6.68(1H,
d,J=7Hz),7.45(1H,d,J=9H
z),7.49(1H,s)
mp;96−97℃
【0035】
【実施例1】N−[1−[(2,4−ジアミノ−6−プテリジニル)
メチル]インドリン−5−カルボニル]−L−グルタミ
ン酸ジエチルの合成
【0036】参考例3.の化合物(214mg)と6−
ブロモメチル−2,4−ジアミノプテリジン臭化水素酸
塩・イソプロパノール付加物(250mg)をジメチル
アセトアミド(3ml)に懸濁し、50−55℃で4時
間撹拌した。冷却後、反応液にトリエチルアミン(12
4mg)を含む水(15ml)を加え撹拌し、次いでク
ロロホルム(350ml)で4回に分けて抽出した。有
機層を硫酸マグネシウムで乾燥後、溶媒を減圧下にて留
去し、得られた残渣をシリカゲルカラムクロマトグラフ
ィーに付し、溶出溶媒としてクロロホルム:メタノール
=10:1の混合溶媒を用い、目的物(200mg)を
得た。
【0037】1H−NMR(DMSO−d6,δ):
1.22(3H,t,J=7Hz),1,30(3H,
t,J=7Hz),2.0−2.5(4H,m),3.
07(2H,t,J=8Hz),3.57(2H,t,
J=8Hz),4.10(2H,q,J=7Hz),
4.23(2H,q,J=7Hz),4.79(1H,
m),5.24(2H,s),6.51(1H,d,J
=9Hz),6.76(1H,d,J=7Hz),7.
57(1H,s),7.59(1H,d,J,=9H
z),8.82(1H,s)
mp;168−170℃
【0038】
【実施例2】N−[1−[(2,4−ジアミノ−6−プテリジニル)
メチル]インドリンカルボニル]−L−グルタミン酸
(化合物1)の合成
【0039】実施例1.の化合物(170mg)をエタ
ノール(33ml)に溶解し35℃で1N−水酸化ナト
リウム水溶液(0.84ml)を加え、同温度で4.5
時間撹拌した。更に25℃で20時間撹拌を続けた後、
反応液に水(2ml)を加えた。氷−水冷却下、反応液
を1N−塩酸でpH=3.7に調整し、冷所で一夜放置
した。析出した沈殿物を濾取し、目的物(130mg)
を得た。
【0040】1H−NMR(DMSO−d6,δ):
1.94(2H,m),2.32(2H,m),2.9
8(2H,t,J=8Hz),3.56(2H,t,J
=8Hz),4.29(1H,m),4.53(2H,
s),6.71(1H,d,J=9Hz),7.57
(1H,s),7.59(1H,d,J=9Hz),
8.72(1H,s)
mp;201−204℃(dec.)
【0041】
【参考例4】N−(1−カルボベンゾキシインドリ−5−カルボニ
ル)−L−α−アミノアジピン酸ジメチルの合成
【0042】1−カルボベンゾキシインドリン−5−カ
ルボン酸(3.1mg)を塩化チオニル(10ml)に
懸濁後、触媒量のジメチルホルムアミドを加え、室温で
2時間撹拌した。次いで減圧下に過剰の塩化チオニルを
留去し、残渣をn−ヘキサンでトリチュレートした。得
られた結晶を濾過した後、ジクロロメタン(30ml)
に溶解しこのジクロロメタン溶解を氷−水冷却下、L−
α−アミノアジピン酸ジメチル塩酸基(2.7g)を含
む水溶液(30ml)にて滴下した。さらに、この反応
溶液に炭酸カリウム(5.8g)を添加した。室温で、
終夜撹拌後反応混合液を飽和炭酸水素ナトリウム溶液に
あけクロロホルムにて有機物を抽出した。クロロホルム
層を1N−塩酸で洗浄し、硫酸ナトリウムで乾燥後、減
圧下に溶媒を留去した。得られた残渣をシリカゲルカラ
ムクロマトグラフィーに付し、溶出溶媒としてクロロホ
ルム:メタノール=100:1の混合溶媒を用い目的物
(3.1mg)を得た。
【0043】1H−NMR(CDCl3,δ):1.6
−2.1(4H,m),2.36(2H,t,J=6.
8Hz),3.13(2H,m),3.66(3H,
s),3.77(3H,s),4.09(2H,m),
4.78(1H,m),5.27(2H,bs),6.
80(1H,d,J=7.8Hz),7.2−7.5
(6H,m),7.63(2H,m)
【0044】
【参考例5】N−(インドリン−5−カルボニル)−L−α−アミノ
アジピン酸ジメチルの合成
【0045】アニソール(1.5g)の30%臭化水素
−酢酸(15ml)溶液に参考例4.の化合物(1.5
g)を加え4時間室温にて撹拌した。次いで反応液に大
量のエーテルを加えたところ赤褐色の油状物質が沈殿し
た。大部分のエーテル層を除き油状物質をクロロホルム
に懸濁させ、この懸濁液を飽和炭酸水素ナトリウム溶液
で洗浄し、クロロホルム層を分取した。クロロホルム層
を硫酸ナトリウムで乾燥し、減圧下にて溶媒を留去し目
的物(960mg)を得た。
【0046】1H−NMR(CDCl3,δ):1.6
−2.1(4H,m),2.36(2H,t,J=6.
8Hz),3.07(2H,m),3.66(2H,
m),3.66(3H,s),3.77(2H,s),
4.78(1H,m),6.62(2H,m),7.5
4(2H,m)
【0047】
【実施例3】N−[1−[(2,4−ジアミノ−6−プテリジニル)
メチル]−インドリン−5−カルボニル]−L−α−ア
ミノアジピン酸ジメチルの合成
【0048】参考例5.の化合物(960mg)と6−
ブロモメチル−2,4−ジアミノプテリジン臭化水素酸
塩・イソプロパノール付加物(1140mg)をジメチ
ルアセトアミド(20ml)に懸濁し、50〜60℃で
6時間撹拌した。冷却後、飽和炭酸水素ナトリウム溶液
にあけ、クロロホルムで3回に分けて目的物を抽出し
た。有機層を硫酸ナトリウムで乾燥後、溶媒を減圧下に
留去し、得られた残渣をシリカゲルカラムクロマトグラ
フィーに付し、溶出溶媒としてクロロホルム:メタノー
ル=100:10の混合溶媒を用いて目的物(520m
g)を得た。
【0049】1H−NMR(CDCl3,δ):1.6
−2.1(4H,m),2.38(2H,t,J=6.
8Hz),3.07(2H,m),3.57(2H,
m),3.67(3H,s),3.78(3H,s),
4.53(2H,s),4.74(1H,m),6.5
2(1H,d,J=8.3Hz),7.01(1H,
d,J=7.8Hz),7.57(2H,m),8.7
7(1H,s)
【0050】
【実施例4】N−[1−[(2,4−ジアミノ−6−プテリジニル)
メチル]−インドリン−5−カルボニル]−L−α−ア
ミノアジピン酸の合成
【0051】実施例3.の化合物(400mg)をエタ
ノール(22ml)に溶解し、35℃で1N−水酸化ナ
トリウム水溶液(3.1ml)を加え、同温度で4時間
撹拌した。さらに25℃で20時間撹拌を続けた後、反
応液に水(3ml)を加え、減圧下に、この反応溶液を
乾固した。このとき外温は30℃を越えないようにし
た。得られた黄色固形物を水(10ml)に溶解し、1
N−塩酸でpH=3.7に調整し、冷蔵庫の中で2時間
放置した。析出した沈殿物を濾取し、目的物(320m
g)を得た。
【0052】1H−NMR(CDCl3,δ):1.4
−1.9(4H,m),2.23(2H,t,J=6.
8Hz),3.01(2H,m),3.58(2H,
m),4.32(1H,m),4.55(2H,s),
6.69(1H,d,J=8.3Hz),7.63(2
H,m),8.10(1H,d,J=8.3Hz),
8.72(1H,s)
【0053】
【参考例6】Nα−(1−カルボベンゾキシインドリン−5−カルボ
ニル)−Nδ−ベンゾイル−L−オルニチンンメチルエ
ステルの合成
【0054】1−カルボベンゾキシインドリン−5−カ
ルボン酸(180mg)に塩化チオニル(1.5ml)
を加え、懸濁液とし、さらにこの懸濁液に触媒量のジメ
チルホルムアミドを添加し室温にて2時間撹拌した。次
に反応液を減圧にて濃縮乾固した。得られた固形物をジ
クロロメタン(4ml)に溶解させ、この溶液にNδ−
ベンゾイル−L−オルニチンメチルエステル(150m
g)、炭酸カルシウム(750mg)を加え、さらに水
(4ml)を加え室温にて激しく12時間撹拌した。次
に反応液を水にあけ、クロロホルムで抽出し、さらにク
ロロホルム層を1N−塩酸溶液で洗浄し硫酸ナトリウム
で乾燥した。溶媒を減圧下にて留去し、得られた残渣を
シリカゲルクロマトグラフィーに付し、溶出溶媒として
クロロホルム:メタノール=100:3を用い目的物
(140mg)を得た。
【0055】1H−NMR(CDCl3,δ):1.6
−2.2(4H,m),3.15(2H,t,J=8.
8Hz),3.56(2H,m),3.78(3H,
s),4.10(2H,t,J=8.8Hz),4.8
2(1H,m),5.27(2H,s),6.70(1
H,m),6.89(1H,d,J=8.8Hz),
7.20(8H,m),7.68(2H,m),7.8
0(2H,m)
【0056】
【参考例7】
Nα−(インドリン−5−カルボニル)−Nδ−ベンゾ
イル−L−オルニチンメチルエステルの合成
【0057】フェノール(150mg)の30%臭化水
素−酢酸(2ml)溶液に参考例6.の化合物(140
mg)を加え4時間室温にて撹拌した。次に反応液に大
量のエーテルを加えたところ赤褐色の油状物質が沈殿し
た。大部分のエーテル層を除き油状物質をクロロホルム
に懸濁させ、この懸濁液を飽和炭酸水素ナトリウム溶液
で洗浄し、クロロホルムで抽出した。クロロホルム層を
硫酸ナトリウムで乾燥し、減圧下にて溶媒を留去し目的
物(50mg)を得た。
【0058】1H−NMR(CDCl3,δ):1.6
−2.1(4H,m),3.02(2H,t,J=8.
8Hz),3.56(2H,m),3.62(2H,
t,J=8.8Hz),3.75(3H,s),4.7
9(1H,m),6.55(1H,d,J=7.8H
z),6.86(2H,m),6.99(1H,m),
7.1−7.6(5H,m),7.82(2H,m)
【0059】
【実施例5】Nα−[1−[(2,4−ジアミノ−6−プテリジニ
ル)メチル]−インドリン−5−カルボニル]−Nδ−
ベンゾイル−L−オルニチンメチルエステルの合成
【0060】参考例7.の化合物(50mg)と6−ブ
ロモメチル−2,4−ジアミノプテリジン臭化水素酸塩
イソプロパノール付加物(44mg)をジメチルアセト
アミド(1ml)に懸濁し、50〜55℃で4時間撹拌
した。冷却後、反応液にトリエチルアミン(22mg)
を含む水(3ml)を加え撹拌し、次にクロロホルムで
抽出した。クロロホルム層を硫酸ナトリウムで乾燥後、
溶媒を減圧下で留去し、得られた残渣をシリカゲルクロ
マトグラフィーに付し、溶出溶媒としてクロロホルム:
メタノール=10:1の混合溶媒を用い目的物(34m
g)を得た。
【0061】1H−NMR(CDCl3,δ):1.6
−2.2(4H,m),3.07(2H,t,J=8.
8Hz),3.50(2H,m),3.56(2H,
t,J=8.8Hz),3.79(3H,s),4.5
3(2H,s),4.6(1H,s),6.52(1
H,d,J=8.3Hz),7.19(1H,d,J=
7.6Hz),7.45(3H,m),7.62(2
H,m),7.80(2H,m),8.76(1H,
s)
【0062】
【実施例6】Nα−[1−[(2,4−ジアミノ−6−プテリジニ
ル)メチル]−インドリン−5−カルボニル]−Nδ−
ベンゾイル−L−オルニチンの合成
【0063】実施例5.の化合物(34mg)をエタノ
ール(5ml)に溶解し、さらに1N−水酸化ナトリウ
ム溶液(0.1ml)を加え、35℃で4.5時間撹拌
した。25℃で20時間撹拌した後に反応液に水(1m
l)を加え、減圧下にてこの反応液を乾固した。このと
き外温は30℃を超えないようにした。得られた黄色固
形物を水(5ml)に溶解し、1N−塩酸でpH=3.
7に調整し、冷蔵庫の中で2時間放置した。析出した沈
殿物を濾取し、目的物(26mg)を得た。
【0064】1H−NMR(DMSO−d6,δ):
1.64(2H,m),1.83(2H,m),2.9
8(2H,t,J=8.3Hz),3.57(2H,
t,J=8.3Hz),4.36(1H,m),4.5
3(2H,s),6.64(2H,m),7.45(3
H,m),7.59(2H,m),7.82(2H,
m),8.12(1H,d,J=8.6Hz),8.4
3(1H,m),8.69(1H,s)
mp;179−183℃(dec.)
【0065】
【参考例8】N−フタロイル−N−カルボベンゾキシ−オルニチン
メチルエステルの合成
【0066】N−カルボベンゾキシ−L−オルニチン
(2.0g)のジクロロメタン(70ml)溶液に無水
フタル酸(2.45g)を加え、次いで水(70m
l)、炭酸カリウム(1.12g)を加え15時間室温
にて撹拌した。反応液を減圧にて60mlまで濃縮し1
N−塩酸でpH=3に調整し析出した沈殿を濾取し真空
乾燥をした。得られた白色固体を低水分メタノール(8
0ml)に溶解し、この溶液を−30℃まで冷却し、1
0分撹拌した。次に、同温にて塩化チオニル(2ml)
をゆっくりと滴下した。反応溶液をゆっくり室温にもど
し、さらに2時間還流を行った。溶媒を減圧にて留去
し、得られた残渣をシリカゲルクロマトグラフィーに付
し、溶出溶媒としてクロロホルム:メタノール=10
0:1を用い目的物(2.16g)を得た。
【0067】1H−NMR(CDCl3,δ):1.6
−2.0(4H,m),3.69(5H,m),4.2
0(1H,m),5.06(2H,s),5.70(1
H,m),7.29(5H,m),7.66(2H,
m),7.81(2H,m)
【0068】
【参考例9】N−フタロイル−オルニチン メチルエステルの合成
【0069】参考例8.の化合物(2.16g)のメタ
ノール溶液(100ml)に、10%パラジウム−炭素
(500mg)を加えた後、水素雰囲気下室温にて20
時間撹拌した。セライトを用いてパラジウム−炭素を濾
去し、減圧下にて溶媒を留去した。得られた残渣をシリ
カゲルクロマトグラフィーに付し、溶出溶媒としてクロ
ロホルム:メタノール=100:3を用い目的物(22
3mg)を得た。
【0070】1H−NMR(CDCl3,δ):1.7
−2.1(4H,m),3.75(2H,m),3.8
3(3H,s),7.76(2H,m),7.84(2
H,m)
【0071】
【参考例10】
N−(1−カルボベンゾキシインドリン−5−カルボニ
ル)フタロイル−オルニチンメチルエステルの合成
【0072】1−カルボベンゾキシインドリン−5−カ
ルボキシリックアシッド(297mg)に塩化チオニル
(2.5ml)を加え、懸濁液とし、さらにこの懸濁液
に触媒量のジメチルホルムアミドを添加し室温にて2時
間撹拌した。次に反応液を減圧にて濃縮乾固した。得ら
れた固形物をジクロロメタン(7ml)に溶解させ、こ
の溶液に参考例9.の化合物(250mg)、炭酸カリ
ウム(640mg)を加え、さらに水(7ml)を加え
室温にて激しく12時間撹拌した。次に反応液を水にあ
けクロロホルムで抽出し、さらにクロロホルム層を1N
−塩酸溶液で洗浄し、硫酸ナトリウムで乾燥した。溶媒
を減圧下にて留去した。得られた残渣をシリカゲルクロ
マトグラフィーに付し、溶出溶媒としてクロロホルム:
メタノール=100:3を用い目的物(330mg)を
得た。
【0073】1H−NMR(CDCl3,δ):1.6
−2.1(4H,m),3.12(2H,t,J=8.
8Hz),3.72(2H,m),3.76(3H,
s),4.08(2H,t,J=8.8Hz),4.8
4(1H,m),5.27(2H,s),6.80(1
H,d,J=7.8Hz),7.1−7.5(6H,
m),7.5−7.9(6H,m)
【0074】
【参考例11】N−(インドリン−5−カルボニル)−N−フタロイル
−オルニチン メチルエステルの合成
【0075】フェノール(300mg)の30%臭化水
素−酢酸(8ml)溶液に参考例10.の化合物(33
0mg)を加え4時間、室温にて撹拌した。次に反応液
に大量のエーテルを加えたところ赤褐色の油状物質が沈
殿した。大部分のエーテル層を除き油状物質をクロロホ
ルムに懸濁させ、この懸濁液を飽和炭酸水素ナトリウム
溶液で洗浄し、クロロホルムで抽出した。クロロホルム
層を硫酸ナトリウムで乾燥し、減圧下にて溶媒を留去
し、目的物(147mg)を得た。
【0076】1H−NMR(CDCl3,δ):1.6
−2.1(4H,m),3.04(2H,t,J=8.
3Hz),3.62(2H,t,J=8.3Hz),
3.72(2H,m),3.75(3H,s),4.8
6(1H,m),6.5−6.7(2H,m),7.5
2(2H,m),7.68(2H,m),7.82(2
H,m)
【0077】
【実施例7】N−[1−[2,4−ジアミノ−6−プテリジニル)メ
チル]−インドリン−5−カルボニル]−N−フタロイ
ル−オルニチン メチルエステルの合成
【0078】参考例11.の化合物(146mg)と6
−ブロモメチル−2,4−ジアミノプテリジン臭化水素
酸塩イソプロパノール付加物(115mg)をジメチル
アセトアミド(1.0ml)に懸濁し、50〜55℃で
4時間撹拌した。冷却後、反応液のトリエチルアミン
(30mg)を含む水(4ml)を加え撹拌し、次にク
ロロホルムで抽出した。クロロホルム層を硫酸ナトリウ
ムで乾燥後、溶媒を減圧下で留去し、得られた残渣をシ
リカゲルクロマトグラフィーに付し、溶出溶媒としてク
ロロホルム:メタノール=10:1の混合溶媒を用い目
的物(140mg)を得た。
【0079】1H−NMR(CDCl3,δ):1.7
−2.2(4H,m),3.06(2H,t,J=8.
3Hz),3.56(2H,t,J=8.3Hz),
3.72(2H,m),3.76(3H,s),4.5
3(2H,s),4.88(1H,m),6.45−
6.62(2H,m),7.56(2H,m),7.7
1(2H,m),7.84(2H,m),8.82(1
H,s)
【0080】
【実施例8】N−[1−[(2,4−ジアミノ−6−プテリジニル)
メチル]−インドリン−5−カルボニル]−N−ヘミフ
タロイルーオルニチン(化合物2)の合成
【0081】実施例7.の化合物(140mg)を2N
−水酸化ナトリウム溶液(10ml)に懸濁させ、30
℃で12時間撹拌した。減圧下にてこの反応液を乾固
し、得られた黄色固形物を水(5ml)に溶解し、1N
−塩酸でpH=3.7に調整し、冷蔵庫の中で2時間放
置した。析出した沈殿物を濾取した。得られた黄色固形
物をシリカゲルクロマトグラフィーに付し、溶出溶媒と
してクロロホルム:メタノール:28%−アンモニア水
=5:4:1の混合溶媒を用い目的物(20mg)を得
た。
【0082】1H−NMR(DMSO−d6,δ):
1.5−2.1(4H,m),3.14(2H,t,J
=8.3Hz),3.58(2H,t,J=8.3H
z),4.38(1H,m),4.54(2H,s),
6.71(1H,m),7.3−7.6(4H,m),
7.6−7.8(3H,m),8.08(1H,m),
8.71(1H,s)
mp;195−199℃(dec.)
【0083】
【参考例12】N−(3−メトキシカルボニルベンゾイル)−N−カル
ボベンゾキシ−オルニチン メチルエステルの合成
【0084】N−カルボベンゾキシ−L−オルニチン
(2.4g)のジクロロメタン(40ml)溶液にイソ
フタル酸モノメチルエステルクロライド(2.1g)を
加え、次いで水(40ml)、炭酸カリウム(2.4
g)を加え15時間室温にて撹拌した。反応液を減圧に
て30mlまで濃縮し1N−塩酸でpH=3に調整し析
出した沈殿を濾取し真空乾燥をした。得られた白色固体
を低水分メタノール(100ml)に溶解し、この溶液
を−30℃まで冷却し、10分撹拌した。次に、同温に
て塩化チオニル(3ml)をゆっくりと滴下した。反応
溶液をゆっくり室温にもどし、さらに2時間還流を行っ
た。溶媒を減圧にて留去し、得られた残渣をシリカゲル
クロマトグラフィーに付し、溶出溶媒としてクロロホル
ム:メタノール=100:1を用い目的物(600m
g)を得た。
【0085】1H−NMR (CDCl3,δ):1.
6−2.0(4H,m),3.46(2H,m),3.
70(3H,s),3.89(3H,s),4.34
(1H,m),5.08(2H,s),5.88(1
H,d,J=7.8Hz),7.31(5H,s),
7.45(1H,m),8.05(2H,m),8.4
1(1H,s)
【0086】
【参考例13】N−(3−メトキシカルボニルベンゾイル)−オルニチ
ン メチルエステルの合成
【0087】参考例12.の化合物(600mg)のメ
タノール溶液(100ml)に、10%パラジウム−炭
素(100mg)を加えた後、水素雰囲気下室温にて2
0時間撹拌した。セライトを用いてパラジウム−炭素を
濾去し、減圧下にて溶媒を留去した。得られた残渣をシ
リカゲルクロマトグラフィーに付し、溶出溶媒としてク
ロロホルム:メタノール=100:3を用い目的物(3
60mg)を得た。
【0088】1H−NMR(CDCl3,δ):1.6
−2.0(4H,m),3.50(3H,m),3.7
2(3H,s),3.92(3H,s),7.49(1
H,t,J=7.8Hz),7.63(1H,m),
8.0−8.2(2H,m),8.43(1H,s)
【0089】
【参考例14】N−(1−カルボベンゾキシインドリン−5−カルボニ
ル)−N−(3−メトキシカルボニルベンゾイル)−オ
ルニチン メチルエステルの合成
【0090】1−カルボベンゾキシインドリン−5−カ
ルボキシリックアシッド(350mg)に塩化チオニル
(5ml)を加え、懸濁液とし、さらにこの懸濁液に触
媒量のジメチルホルムアミドを添加し室温にて2時間撹
拌した。次に反応液を減圧にて濃縮乾固した。得られた
固形物をジクロロメタン(7ml)に溶解させ、この溶
液に参考例13.の化合物(360mg)、炭酸カリウ
ム(650mg)を加え、さらに水(7ml)を加え室
温にて激しく12時間撹拌した。次に反応液を水にあけ
クロロホルムで抽出し、さらにクロロホルム層を1N−
塩酸溶液で洗浄し、硫酸ナトリウムで乾燥した。溶媒を
減圧下にて留去した。得られた残渣をシリカゲルクロマ
トグラフィーに付し、溶出溶媒としてクロロホルム:メ
タノール=100:3を用い目的物(390mg)を得
た。
【0091】1H−NMR(CDCl3,δ):1.6
−2.1(4H,m),3.08(2H,t,J=8.
3Hz),3.52(2H,m),3.75(3H,
s),3.88(3H,s),4.06(2H,t,J
=8.3Hz),4.78(1H,m),5.26(2
H,bs),7.16(1H,d,J=7.3Hz),
7.2−7.6(7H,m),7.65(2H,m),
7.9−8.1(2H,m),8.43(1H,s)
【0092】
【参考例15】N−(インドリン−5−カルボニル)−N−(3−メト
キシカルボニルベンゾイル)−オルニチンメチルエステ
ルの合成
【0093】アニソール(0.5g)の30%臭化水素
酢酸(6ml)溶液に参考例14.の化合物(390m
g)を加え4時間、室温にて撹拌した。次に反応液に大
量のエーテルを加えたところ赤褐色の油状物質が沈殿し
た。大部分のエーテル層を除き油状物質をクロロホルム
に懸濁させ、この懸濁液を飽和炭酸水素ナトリウム溶液
で洗浄し、クロロホルムで抽出した。クロロホルム層を
硫酸ナトリウムで乾燥し、減圧下にて溶媒を留去した。
得られた白色個体をn−ヘキサン−クロロホルムーメタ
ノールから再結晶し目的物(192mg)を得た。
【0094】1H−NMR(CDCl3,δ):1.7
−2.1(4H,m),3.05(2H,t,J=8.
3Hz),3.53(2H,m),3.67(2H,
t,J=8.3Hz),3.75(3H,s),3.8
9(3H,s),4.75(1H,m),6.73(1
H,d,J=7.8Hz),7.16(1H,d,J=
7.8Hz),7.47(1H,m),7.55(2
H,m),8.09(2H,m),8.45(1H,
s)
【0095】
【実施例9】N−[1−[(2,4−ジアミノ−6−プテリジニル)
メチル]−インドリン−5−カルボニル]−N−(3−
メトキシカルボニルベンゾイル)−オルニチンメチルエ
ステルの合成
【0096】参考例15.の化合物(192mg)と6
−ブロモメチル−2,4−ジアミノプテリジン臭化水素
酸塩(142mg)をジメチルアセトアミド(2.5m
l)に懸濁し、50〜55℃で4時間攪拌した。冷却
後、反応液のトリエチルアミン(43mg)を含む水
(5ml)を加え攪拌し、次にクロロホルムで抽出し
た。クロロホルム層を硫酸ナトリウムで乾燥した後、溶
媒を減圧下で留去し、得られた残渣をシリカゲルクロマ
トグラフィーに付し、溶出溶媒としてクロロホルム:メ
タノール=10:1の混合溶媒を用い目的物(110m
g)を得た。
【0097】1H−NMR(CDCl3,δ):1.7
−2.1(4H,m),3.06(2H,t,J=8.
3Hz),3.55(4H,m),3.78(3H,
s),3.93(3H,s),4.52(2H,s),
4.79(1H,m),6.51(1H,d,J=7.
8Hz),7.05(1H,d,J=7.8Hz),
7.4−7.7(3H,m),8.0−8.2(2H,
m),8.45(1H,m),8.77(1H,s)
【0098】
【実施例10】N−[1−[(2,4−ジアミノ−6−プテリジニル)
メチル]−インドリン−5−カルボニル]−N−イソフ
タロイル−オルニチンの合成
【0099】実施例9.の化合物(110mg)をエタ
ノール(14ml)に溶解し、さらに1N−水酸化ナト
リウム溶液(0.48ml)を加え、35℃で4.5時
間攪拌した。25℃で20時間攪拌した後、反応液に水
(1ml)を加え、減圧下にてこの反応液を乾固した。
このとき外温は30℃を超えないようにした。得られた
黄色固形物を水(5ml)に溶解し、1N−塩酸でpH
=3.7に調整し、冷蔵庫の中で2時間放置した。析出
した沈殿物を濾取し、目的物(78mg)を得た。
【0100】1H−NMR(DMSO−d6,δ):
1.5−2.0(4H,m),3.00(2H,t,J
=8.8Hz),3.32(2H,m),3.59(2
H,t,J=8.8Hz),4.40(1H,m),
4.56(2H,s),6.69(1H,d,J=8.
3Hz),7.56(1H,m),7.63(2H,
m),8.0−8.2(2H,m),8.44(1H,
s),8.65(1H,m),8.73(1H,s)
【0101】
【参考例16】N−(4−メトキシカルボニルベンゾイル)−N−カル
ボベンゾキシ−オルニチン メチルエステルの合成
【0102】N−カルボベンゾキシ−L−オルニチン
(2.0g)のジクロロメタン(60ml)溶液にテレ
フタル酸モノメチルエステルクロライド(3.0g)を
加え、次いで水(60ml)、炭酸カリウム(4.8
g)を加え15時間室温にて攪拌した。反応液を減圧に
て50mlまで濃縮し1N−塩酸でpH=3に調整し析
出した沈殿を濾取し真空乾燥した。得られた白色固体を
低水分メタノール(100ml)に溶解し、この溶液を
−30℃まで冷却し、10分攪拌した。次に、同温にて
塩化チオニル(3ml)をゆっくりと滴下した。反応溶
液をゆっくり室温にもどし、さらに2時間還流を行っ
た。溶媒を減圧にて留去し、得られた残渣をシリカゲル
クロマトグラフィーに付し、溶出溶媒としてクロロホル
ム:メタノール=100:1を用い目的物(710m
g)を得た。
【0103】1H−NMR(CDCl3,δ):1.6
−2.1(4H,m),3.51(2H,m),3.7
4(3H,s),3.94(3H,s),4.43(1
H,m),5.11(2H,s),5.53(1H,
m),6.63(1H,bs),7.34(5H,
s),7.83(2H,d,J=8.8Hz),8.0
8(2H,d,J=8.8Hz)
【0104】
【参考例17】N−(4−メトキシカルボニルベンゾイル)−オルニチ
ン メチルエステルの合成
【0105】参考例16.の化合物(710mg)のメ
タノール溶液(100ml)に10%パラジウム一炭素
(100mg)を加えた後、水素雰囲気下室温にて20
時間攪拌した。セライトを用いてパラジウム一炭素を濾
去し、減圧下にて溶媒を留去した。得られた残渣をシリ
カゲルクロマトグラフィーに付し、溶出溶媒としてクロ
ロホルム:メタノール=100:3を用い目的物(41
0mg)を得た。
【0106】1H−NMR(CDCl3,δ):1.6
−2.1(4H,m),3.49(3H,m),3.7
3(3H,s),3.94(3H,s),7.20(1
H,m),7.84(2H,d,J=8.3Hz),
8.09(2H,d,J=8.3Hz)
【0107】
【参考例18】N−(1−カルボベンゾキシインドリン−5−カルボニ
ル)−N−(4−メトキシカルボニルベンゾイル)−オ
ルニチン メチルエステルの合成
【0108】1−カルボベンゾキシインドリン−5−カ
ルボキシリックアシッド(260mg)に塩化チオニル
(2.5ml)を加え、懸濁液とし、さらにこの懸濁液
に触媒量のジメチルホルムアミドを添加し室温にて2時
間攪拌した。次に反応液を減圧にて濃縮乾固した。得ら
れた固形物をジクロロメタン(6ml)に溶解させ、こ
の溶液に参考例17.の化合物(245mg)、炭酸カ
リウム(812mg)を加え、さらに水(6ml)を加
え室温にて激しく12時間攪拌した。次に反応液を水に
あけクロロホルムで抽出し、さらにクロロホルム層を1
N−塩酸溶液で洗浄し、硫酸ナトリウムで乾燥した。溶
媒を減圧下にて留去した。得られた残渣をシリカゲルク
ロマトグラフィーに付し、溶出溶媒としてクロロホル
ム:メタノール100:3を用い目的物(310mg)
を得た。
【0109】1H−NMR(CDCl3,δ):1.7
−2.2(4H,m),3.16(2H,t,J=8.
3Hz),3.61(1H,m),3.79(3H,
s),3.94(3H,s),4.11(2H,t,J
=8.3Hz),4.83(1H,m),5.29(2
H,s),6.89(1H,d,J=7.3Hz),
7.02(1H,m),7.40(5H,m),7.6
6(2H,d,J=7.3Hz),7.90(2H,
d,J=8.8Hz),8.08(2H,d,J=8.
8Hz)
【0110】
【参考例19】N−(インドリン−5−カルボニル)−N−(4−メト
キシカルボニルベンゾイル)−オルニチンメチルエステ
ルの合成
【0111】フェノール(1.0g)の30%臭化水素
−酢酸(10ml)溶液に参考例18.の化合物(40
0mg)を加え4時間、室温にて攪拌した。次に反応液
に大量のエーテルを加えたところ赤褐色の油状物質が沈
殿した。大部分のエーテル層を除き油状物質をクロロホ
ルムに懸濁させ、この懸濁液を飽和炭酸水素ナトリウム
溶液で洗浄し、目的物をクロロホルムで抽出した。クロ
ロホルム層を硫酸ナトリウムで乾燥し、減圧下にて溶媒
を留去した。得られた白色固体をn−ヘキサン−クロロ
ホルム−メタノールから再結晶し目的物(145mg)
を得た。
【0112】1H−NMR(CDCl3,δ):1.6
−2.1(4H,m),3.05(2H,t,J=8.
3Hz),3.48(2H,m),3.62(2H,
t,J=8.3Hz),3.76(3H,s),3.9
4(3H,s),4.75(1H,m),6.57(1
H,d,J=7.8Hz),7.19(1H,d,J=
7.8Hz),7.55(2H,m),7.89(2
H,d,J=8.3Hz),8.07(2H,d,J=
8.3Hz)
【0113】
【実施例11】N−[1−[(2,4−ジアミノ−6−プテリジニル)
メチル]インドリン−5−カルボニル]−N−(4−メ
トキシカルボニルベンゾイル)−オルニチンメチルエス
テルの合成
【0114】参考例19.の化合物(140mg)と6
−ブロモメチル−2,4−ジアミノプテリジン臭化水素
酸塩(105mg)をジメチルアセトアミド(2.0m
l)に懸濁し、50〜55℃で4時間攪拌した。冷却
後、反応液のトリエチルアミン(32mg)を含む水
(4ml)を加え攪拌し、次に目的物をクロロホルムで
抽出した。クロロホルム層を硫酸ナトリウムで乾燥後、
溶媒を減圧下で留去し、得られた残渣をシリカゲルクロ
マトグラフィーに付し、溶出溶媒としてクロロホルム:
メタノール=10:1の混合溶媒を用い目的物(180
mg)を得た。
【0115】1H−NMR(CDCl3,δ):1.6
−2.1(4H,m),3.08(2H,t,8.8H
z),3.4−3.7(4H,m),3.79(3H,
s),3.94(3H,s),4.54(2H,s),
4.83(1H,m),6.52(1H,d,J=8.
3Hz),6.79(1H,d,J=6.8Hz),
7.17(1H,m),7.59(2H,m),7.9
2(2H,d,J=8.3Hz),8.09(2H,
d,J=8.3Hz),8.81(1H,s)
【0116】
【実施例12】
N−[1−[(2,4−ジアミノ−6−プテリジニル)
メチル]インドリン−5−カルボニル]−N−テレフタ
ロイル−オルニチンの合成
【0117】実施例11.の化合物(150mg)をエ
タノール(24ml)に溶解し、さらに1N−水酸化ナ
トリウム溶液(0.8ml)を加え、35℃で4.5時
間攪拌した。25℃で20時間攪拌した後、反応液に水
(1ml)を加え、減圧下にてこの反応液を乾固した。
このとき外温は30℃を超えないようにした。得られた
黄色固形物を水(5ml)に溶解し、1N−塩酸でpH
=3.7に調整し、冷蔵庫の中で2時間放置した。析出
した沈澱物を濾取し、目的物(109mg)を得た。
【0118】1H−NMR(CDCl3,δ):1.5
−2.0(4H,m),3.00(2H,t,J=8.
8Hz),3.30(2H,m),3.58(2H,
t,J=8.8Hz),4.36(1H,m),4.5
4(2H,s),6.68(1H,d,J=8.8H
z),7.62(2H,m),7.91(2H,d,J
=8.3Hz),7.99(2H,d,J=8.3H
z),8.10(1H,d,J=7.8Hz),8.6
1(1H,m),8.71(1H,s)
mp;215−220℃(dec.)
【0119】
【参考例20】N−t−ブトキシカルボニル−γ−アニリド−L−グル
タミン酸α−ベンジルエステルの合成
【0120】N−t−ブトキシカルボニル−L−グルタ
ミン酸α−ベンジルエステル(2.2g)とトリエチル
アミン(0.92ml)のテトラヒドロフラン溶液(8
ml)に、−20℃、窒素雰囲気下、クロル炭酸イソブ
チル(0.8ml)のテトラヒドロフラン溶液(2m
l)を加え30分攪拌した。次いで、アニリン(0.5
ml)を加えた後、1時間攪拌した。徐々に室温に戻
し、さらに20時間攪拌した。減圧で溶媒を留去し、得
られた残渣をクロロホルムに溶解した。クロロホルム層
を飽和炭酸水素ナトリウム水溶液で洗浄し、硫酸ナトリ
ウムで乾燥した後、減圧下で濃縮した。得られた残渣を
シリカゲルクロマトグラフィーに付し、溶出溶媒として
クロロホルム:メタノール=99:1を用いて目的物
(1.7g)を得た。
【0121】1H−NMR(CDCl3,δ):1.4
4(9H,s),1.79−1.97(1H,m),
2.27−2.40(2H,m),4.32−4.44
(1H,m),5.16(2H,s),5.22−5.
38(1H,m),7.08(1H,t,J=7.3H
z),7.26−7.33(7H,m),7.55(2
H,d,J=7.8Hz),8.42(1H,s)
【0122】
【参考例21】γ−アニリド−L−グルタミン酸α−ベンジルエステル
の合成
【0123】参考例20.の化合物(1.7g)を氷冷
下でトリフルオロ酢酸(8ml)に溶解し30分攪拌し
た。減圧下で溶媒を留去し、残渣をクロロホルムに溶解
した。クロロホルム層を飽和炭酸水素ナトリウム水溶液
で洗浄した後、硫酸ナトリウムで乾燥した。減圧下で溶
媒を留去し、目的物(1.3g)を得た。
【0124】1H−NMR(CDCl3,δ):1.8
6−2.00(1H,m),2.17−2.38(1
H,m),2.42−2.53(2H,m),3.53
−3.60(1H,m),5.15(2H,s),7.
07(1H,t,J=7.3Hz),7.29−7.3
5(7H,m),7.48(2H,d,J=7.8H
z),8.27(1H,bs)
【0125】
【参考例22】N−(1−カルボベンゾキシインドリン−5−カルボニ
ル)−γ−アニリド−L−グルタミン酸α−ベンジルエ
ステルの合成
【0126】1−カルボベンゾキシインドリン−5−カ
ルボン酸(419mg)に塩化チオニル(2ml)を加
え室温で2時間攪拌した。次に、反応液を減圧下で濃縮
乾固した。得られた固形物をジクロロメタン(2ml)
に溶解させ、この溶液に参考例21.の化合物(400
mg)とトリエチルアミン(0.21ml)の塩化メチ
レン溶液(2ml)を氷冷、窒素雰囲気下で加え一晩攪
拌した。反応液を1N−塩酸、飽和炭酸水素ナトリウム
水溶液、水で順次洗浄し、硫酸ナトリウムで乾燥した
後、減圧下で溶媒を留去した。得られた残渣をシリカゲ
ルクロマトグラフィーに付し、溶出溶媒としてジクロロ
メタン、次いでクロロホルムを用いて目的物(317m
g)を得た。
【0127】1H−NMR(CDCl3,δ):2.1
0−2.20(1H,m),2.29−2.51(3
H,m),3.05(2H,t,J=8.8Hz),
4.06(2H,t,J=8.8Hz),4.76−
4.88(1H,m),5.18(2H,s),5.2
8(2H,bs),7.05(1H,t,J=7.3H
z),7.18(1H,d,J=7.8Hz),7.2
3−7.30(2H,m),7.33(5H,s),
7.39(5H,s),7.43−7.66(4H,
m),7.80−7.84(1H,m),8.57(1
H,bs)
【0128】
【参考例23】N−(1−カルボベンゾキシインドリン−5−カルボニ
ル)−γ−アニリド−L−グルタミン酸の合成
【0129】参考例22.の化合物(580mg)をク
ロロホルム:メタノール=1:2の混合溶媒(30m
l)に溶解し、1N−水酸化ナトリウム水溶液(0.9
8ml)を加え、室温で一晩攪拌した。水浴の温度を3
0℃以下に保ちながら減圧下で溶媒を留去した。得られ
た残渣を水に溶解し、1N−塩酸で酸性にしたところで
クロロホルムを用いて抽出した。クロロホルム層を硫酸
ナトリウム乾燥した後、減圧下で溶媒を留去し、目的物
(413mg)を得た。
【0130】1H−NMR(CDCl3,δ):2.1
7−2.29(2H,m),2.52−2.56(2
H,m),2.79(2H,t,J=7.8Hz),
3.81(2H,t,J=7.8Hz),4.51−
4.61(1H,m),5.17(2H,s),6.9
4(1H,t,J=7.3Hz),7.13(2H,
t,J=7.8Hz),7.34(5H,s),7.4
3−7.65(5H,m),8.03(1H,bs),
9.02(1H,s)
【0131】
【参考例24】N−(1−カルボベンゾキシインドリン−5−カルボニ
ル)−γ−アニリド−L−グルタミン酸α−メチルエス
テルの合成
【0132】参考例23.の化合物(470mg)を乾
燥メタノール(20ml)に溶解し、トリメチルシリル
ジアゾメタン(2ml)を加え、10時間攪拌した。さ
らにトリメチルシリルジアゾメタン(3ml)を加え、
20時間攪拌した。減圧下で溶媒を留去した後、得られ
た残渣をシリカゲルクロマトグラフィーに付し、溶出溶
媒としてクロロホルム、次いでクロロホルム:メタノー
ル=199:1を用いて目的物(252mg)を得た。
【0133】1H−NMR(CDCl3,δ):2.0
6−2.21(1H,m),2.31−2.56(3
H,m),3.08(2H,t,J=8.8Hz),
3.77(3H,s),4.08(2H,t,J=8.
8Hz),4.77−4.87(1H,m),5.28
(2H,s),7.07(1H,t,J=7.3H
z),7.15(1H,d,J=7.8Hz),7.2
8(2H,t,J=7.8Hz),7.37−7.43
(5H,m),7.58(2H,d,J=7.8H
z),7.62−7.68(2H,m),7.86(1
H,bs),8.67(1H,bs)
【0134】
【参考例25】N−(インドリン−5−カルボニル)−γ−アニリド−
L−グルタミン酸α−メチルエステルの合成
【0135】参考例24.の化合物(250mg)のメ
タノール溶液(10ml)に10%パラジウム−炭素
(50mg)を加えた後、水素雰囲気下、室温で15時
間攪拌した。セライトを用いてパラジウム−炭素を濾去
し、減圧下で溶媒を留去した。得られた残渣をシリカゲ
ルクロマトグラフィーに付し、溶出溶媒としてクロロホ
ルム:メタノール=99:1、次いでクロロホルム:メ
タノール=19:1を用いて目的物(172mg)を得
た。
【0136】1H−NMR(CDCl3,δ):1.9
9−2.13(1H,m),2.36.2.55(3
H,m),3.03(2H,t,J=8.8Hz),
3.64(2H,t,J=8.8Hz),3.77(3
H,s),4.08(1H,bs),4.79−4.8
8(1H,m),6.55(1H,d,J=8.3H
z),6.92(1H,d,J=7.3Hz),7.0
8(1H,t,J=7.3Hz),7.30(2H,
t,J=7.8Hz),7.53−7.65(4H,
m),9.01(1H,bs)
【0137】
【実施例13】N−[1−[(2,4−ジアミノ−6−プテリジニル)
メチル]−インドリン−5−カルボニル]−γ−アニリ
ド−L−グルタミン酸α−メチルエステルの合成
【0138】参考例25.の化合物(169mg)と6
−ブロモメチル−2,4−ジアミノプテリジン臭化水素
酸塩(223mg)をジメチルアセトアミド(5ml)
に懸濁させ、室温で24時間攪拌した。反応液をシリカ
ゲルクロマトグラフィーに付し、溶出溶媒として酢酸エ
チル、次いでクロロホルム:メタノール=19:1を用
いて目的物(82mg)を得た。
【0139】1H−NMR(CDCl3,δ):2.0
1−2.09(1H,m),2.39−2.48(3
H,m),3.04(2H,t,J=8.8Hz),
3.58(2H,t,J=8.8Hz),3.78(3
H,s),4.53(2H,s),4.79−4.89
(1H,m),6.48(1H,d,J=7.8H
z),6.87(1H,d,J=7.8Hz),7.0
8(1H,t,J=7.8Hz),7.26−7.32
(2H,m),7.59−7.64(4H,m),8.
81(1H,s)
【0140】
【実施例14】N−[1−[(2,4−ジアミノ−6−プテリジニル)
メチル]−インドリン−5−カルボニル]−γ−アニリ
ド−L−グルタミン酸の合成
【0141】実施例13.の化合物(82mg)をエタ
ノール:水=2:1の混合溶媒(15ml)に溶解し、
1N−水酸化ナトリウム水溶液(0.15ml)を加
え、室温で60時間攪拌した。水浴の温度を30℃以下
に保ちながら減圧下で溶媒を留去した。得られた残渣を
飽和炭酸水素ナトリウム水溶液に溶解し、1N−塩酸を
用いてpH=3.7に調整した。析出した橙色沈澱物を
濾取し、目的物(61mg)を得た。
【0142】1H−NMR(DMSO−d6,δ):
1.99−2.23(2H,m),2.42−2.51
(2H,m),2.98(2H,t,J=7.8H
z),3.59(2H,t,J=8.3Hz),4.3
2−4.43(1H,m),4.56(2H,s),
6.70(1H,d,J=7.8Hz),6.90(2
H,bs),7.00(1H,t,J=7.8Hz),
7.26(2H,t,J=7.8Hz),7.55−
7.66(4H,m),7.72−7.85(1H,
m),7.89−7.97(1H,m),8.20(1
H,d,J=7.3Hz),8.75(1H,s),
9.93(1H,s)
【0143】
【参考例26】N−t−ブトキシカルボニル−γ−(2−メトキシカル
ボニルアニリド)−L−グルタミン酸α−ベンジルエス
テルの合成
【0144】N−t−ブトキシカルボニル−L−グルタ
ミン酸α−ベンジルエステル(496mg)のテトラヒ
ドロフラン溶液(5ml)に、氷冷、窒素雰囲気下、
N,N′−カルボニルジイミダゾール(262mg)を
加え1時間攪拌した。次いで、o−アミノ安息香酸メチ
ル(0.19ml)のテトラヒドロフラン溶液(2m
l)を加えた後、5時間攪拌した。徐々に室温に戻し、
さらに48時間攪拌した。減圧下で溶媒を留去し、得ら
れた残渣をシリカゲルクロマトグラフィーに付し、溶出
溶媒としてクロロホルムを用いて目的物(273mg)
を得た。
【0145】1H−NMR(CDCl3,δ):1.4
1(9H,s),2.04−2.18(1H,m),
2.20−2.32(1H,m),2.48−2.57
(2H,m),3.92(3H,s),4.34−4.
47(1H,m),5.18(2H,s),5.19−
5.27(1H,m),7.08(1H,t,J=7.
8Hz),7.34(5H,s),7.53(1H,
t,J=7.3Hz),8.02(1H,d,J=7.
8Hz),8.68(1H,d,J=7.8Hz),1
1.06(1H,s)
【0146】
【参考例27】γ−(2−メトキシカルボニルアニリド)−L−グルタ
ミン酸α−ベンジルエステルの合成
【0147】参考例26.の化合物(632mg)を氷
冷下でトリフルオロ酢酸(4.5ml)に溶解し90分
攪拌した。減圧下で溶媒を留去し、残渣をクロロホルム
に溶解した。クロロホルム層を飽和炭酸水素ナトリウム
水溶液で洗浄し、硫酸ナトリウムで乾燥した後、減圧下
で溶媒を留去した。得られた残渣をシリカゲルクロマト
グラフィーに付し、溶出溶媒としてクロロホルム、次い
でクロロホルム:メタノール=97:3を用いて目的物
(486mg)を得た。
【0148】1H−NMR(CDCl3,δ):1.9
1−2.02(1H,m),2.20−2.30(1
H,m),2.55−2.64(2H,m),3.56
−3.62(1H,m),3.92(3H,s),5.
17(2H,s),7.07(1H,t,J=8.3H
z),7.35(5H,s),7.53(1H,t,J
=8.8Hz),8.02(1H,d,J=8.3H
z),8.69(1H,d,J=8.8Hz),11.
08(1H,bs)
【0149】
【参考例28】1−[(2,4−ジアミノ−6−プテリジニル)メチ
ル]−インドリン−5−カルボン酸の合成
【0150】1−カルボベンゾキシインドリン−5−カ
ルボン酸(87mg)と6−ブロモメチル−2,4−ジ
アミノプテリジン臭化水素酸塩1/2イソプロパノール
付加物(136mg)をジメチルアセトアミド(2m
l)に懸濁させ、55℃で4時間攪拌した。反応液に水
(20ml)を加え、冷蔵庫で一晩放置した。析出した
固体を濾取し、少量の1N−水酸化ナトリウム水溶液に
溶解し、1N−塩酸を用いてpH=6.5に調整した。
析出した褐色沈澱物を濾取、目的物(56mg)を得
た。
【0151】1H−NMR(DMSO−d6,δ):
3.01(2H,t,J=8.8Hz),3.64(1
H,t,J=8.8Hz),4.60(2H,s),
6.68(1H,d,J=8.3Hz),7.16(2
H,bs),7.58(1H,s),7.65(1H,
d,J=8.3Hz),8.09(1H,bs),8.
25(1H,bs),8.77(1H,s)
【0152】
【実施例15】N−[1−[(2,4−ジアミノ−6−プテリジニル)
メチル]−インドリン−5−カルボニル]−γ−(2−
メトキシカルボニルアニリド)−L−グルタミン酸α−
メチルエステルの合成
【0153】参考例28.の化合物(134mg)と1
−ヒドロキシベンゾトリアゾール(108mg)のジメ
チルホルムアミド懸濁液(5ml)に、氷冷、窒素雰囲
気下、ジシクロヘキシルカルボジイミド(123mg)
のジメチルホルムアミド溶液(1.5ml)を加え30
分攪拌した。次いで、参考例27.の化合物のジメチル
ホルムアミド溶液(1.5ml)を加えた後、徐々に室
温に戻し24時間攪拌した。反応液をシリカゲルクロマ
トグラフィーに付し、溶出溶媒として酢酸エチル、次い
でクロロホルム:メタノール=19:1を用いて目的物
(29mg)を得た。
【0154】1H−NMR(CDCl3,δ):2.3
2−2.46(2H,m),2.46−2.70(2
H,m),2.96(2H,t,J=8.8Hz),
3.49(2H,t,J=8.3Hz),3.89(3
H,s),4.46(2H,s),4.83−4.90
(1H,m),5.20(2H,s),6.40(1
H,d,J=8.3Hz),7.05(1H,t,J=
8.3Hz),7.14(1H,d,J=7.8H
z),7.34(5H,s),7.41−7.59(3
H,m),7.96(1H,d,J=8.3Hz),
8.64(1H,d,J=8.3Hz),8.77(1
H,s)
【0155】
【実施例16】N−[1−[(2,4−ジアミノ−6−プテリジニル)
メチル]−インドリン−5−カルボニル]−γ−(2−
カルボキシアニリド)−L−グルタミン酸の合成
【0156】実施例15.の化合物(28mg)をメタ
ノール(2.5ml)に懸濁させ、1N−水酸化ナトリ
ウム水溶液(0.41ml)を加え、10℃で5時間攪
拌した。水浴の温度を30℃以下に保ちながら減圧下で
溶媒を留去した。得られた残渣を飽和炭酸水素ナトリウ
ム水溶液に溶解し、1N−塩酸を用いてpH=3.7に
調整した。析出した橙色沈澱物を濾取し、目的物(21
mg)を得た。
【0157】1H−NMR(DMSO−d6,δ):
1.95−2.25(2H,m),2.39−2.58
(2H,m),2.98(2H,t,J=8.3H
z),3.59(2H,t,J=8.3Hz),4.3
8−4.50(1H,m),4.57(2H,s),
6.69(1H,d,J=8.3Hz),7.12(1
H,t,J=7.8Hz),7.24−7.35(2
H,m),7.51−7.64(3H,m),7.96
(1H,d,J=7.8Hz)8.04−8.39(4
H,m),8.47(1H,d,J=7.8Hz),
8.78(1H,s),11.25(2H,s)
【0158】
【参考例29】N−t−ブトキシカルボニル−L−グルタミン酸α−メ
チルγ−ベンジルジエステルの合成
【0159】N−t−ブトキシカルボニル−L−グルタ
ミン酸γ−ベンジルエステル(5.0g)のジメチルホ
ルムアミド(75ml)溶液に炭酸水素ナトリウム
(2.5g)を懸濁させた後、ヨウ化メチル(10.5
2g)のジメチルホルムアミド(75ml)溶液を加え
室温で24時間攪拌した。反応液を減圧下で濃縮した
後、水(70ml)を加え、酢酸エチル:n−ヘキサン
=1:1溶液で抽出した。有機層を水で洗浄し、硫酸ナ
トリウムで乾燥した後、減圧下で溶媒を留去した。得ら
れた残渣をシリカゲルクロマトグラフィーに付し、溶出
溶媒として酢酸エチル:n−ヘキサン=1:2を用いて
目的物(5.2g)を得た。
【0160】1H−NMR(CDCl3,δ):1.4
3(9H,s),1.92−2.01(1H,m),
2.11−2.37(1H,m),2.51−2.42
(2H,m),3.73(3H,s),4.23−4.
40(1H,m),5.12(2H,s),7.35
(5H,s)
【0161】
【参考例30】N−t−ブトキシカルボニル−L−グルタミン酸α−メ
チルエステルの合成
【0162】参考例29.の化合物(5.2g)のメタ
ノール溶液(30ml)に10%パラジウム−炭素
(1.1g)を加えた後、水素雰囲気下、室温で15時
間攪拌した。セライトを用いてパラジウム−炭素を濾去
し、減圧下で溶媒を留去した。得られた残渣を飽和炭酸
水素ナトリウム水溶液に溶解し、クロロホルムで洗浄し
た。水層を分取した後、5%クエン酸を用いてpH=4
に調整し、クロロホルムで抽出した。クロロホルム層を
硫酸ナトリウムで乾燥した後、減圧下で溶媒を留去し、
目的物(3.9g)を得た。
【0163】1H−NMR(CDCl3,δ):1.4
4(9H,s),1.89−2.04(1H,m),
2.09−2.27(1H,m),3.75(3H,
s),4.34(1H,m),5.17−5.21(1
H,m),9.38(1H,bs)
【0164】
【参考例31】N−t−ブトキシカルボニル−γ−(3−エトキシカル
ボニルアニリド)−L−グルタミン酸α−メチルエステ
ルの合成
【0165】参考例30.の化合物(1.6g)と1−
ヒドロキシベンゾトリアゾール(0.8g)のジクロロ
メタン懸濁液(10ml)に、氷冷、窒素雰囲気下、ジ
シクロヘキシルカルボジイミド(1.5g)のジクロロ
メタン溶液(5ml)を加え30分攪拌した。次いで、
m−アミノ安息香酸エチル(1.5g)を加えた後、徐
々に室温に戻し20時間攪拌した。減圧下で溶媒を留去
し、得られた残渣に酢酸エチルを加え白色不溶物を濾去
した。濾液を減圧下で濃縮し、得られた残渣をシリカゲ
ルクロマトグラフィーに付し、溶出溶媒としてクロロホ
ルム、次いでクロロホルム:メタノール=99:1を用
いて目的物(2.5g)を得た。
【0166】1H−NMR(CDCl3,δ):1.3
8(3H,t,J=7.1Hz),1.47(9H,
s),1.82−2.04(1H,m),2.20−
2.39(1H,m),2.45−2.51(2H,
m),3.74(3H,s),4.32−4.42(1
H,m),4.37(2H,q,J=7.1Hz),
5.37(1H,bd,J=7.3Hz),7.40
(1H,t,J=7.8Hz),7.78(1H,d,
J=7.8Hz),7.96(1H,d,J=9.3H
z),8.13(1H,s),8.83(1H,bs)
【0167】
【参考例32】γ−(3−エトキシカルボニルアニリド)−L−グルタ
ミン酸α−メチルエステルの合成
【0168】参考例31.の化合物(2.5g)を氷冷
下でトリフルオロ酢酸(15ml)に溶解し1時間攪拌
した。減圧下で溶媒を留去し、残渣をクロロホルムに溶
解した。クロロホルム層を飽和炭酸水素ナトリウム水溶
液で洗浄し、硫酸ナトリウムで乾燥した後、減圧下で溶
媒を留去した。得られた残渣をシリカゲルクロマトグラ
フィーに付し、溶出溶媒としてクロロホルム:メタノー
ル19:1を用いて目的物(1.6g)を得た。
【0169】1H−NMR(CDCl3,δ):1.3
9(3H,t,J=7.1Hz),1.74(2H,
s),1.82−1.99(1H,m),2.15−
2.32(1H,m),2.52−2.62(2H,
m),3.54−3.60(1H,m),3.74(3
H,s),4.37(2H,q,J=7.1Hz),
7.39(1H,t,J=7.8Hz),7.77(1
H,d,J=7.3Hz),7.94(1H,d,J=
7.8Hz),7.99(1H,s),8.63(1
H,bs)
【0170】
【参考例33】N−(1−カルボベンゾキシインドリン−5−カルボニ
ル)−γ−(3−エトキシカルボニルアニリド)−L−
グルタミン酸α−メチルエステルの合成
【0171】1−カルボベンゾキシインドリン−5−カ
ルボン酸(612mg)に塩化チオニル(4ml)を加
え室温で2時間攪拌した。次に、反応液を減圧下で濃縮
乾固した。得られた固形物をジクロロメタン(4ml)
に溶解させ、この溶液に、参考例32.の化合物(52
9mg)とトリエチルアミン(0.36ml)のジクロ
ロメタン溶液(4ml)を氷冷、窒素雰囲気下で加え一
晩攪拌した。反応液を2N−塩酸、飽和炭酸水素ナトリ
ウム水溶液、水で順次洗浄し、硫酸ナトリウムで乾燥し
た後、減圧下で溶媒を留去した。得られた残渣をシリカ
ゲルクロマトグラフィーに付し、溶出溶媒としてクロロ
ホルム、次いでクロロホルム:メタノール=99:1を
用いて目的物(870mg)を得た。
【0172】1H−NMR(CDCl3,δ):1.3
7(3H,t,J=7.1Hz),2.22−2.08
(1H,m),2.36−2.57(3H,m),3.
06(2H,t,J=8.8Hz),3.77(3H,
s),4.07(2H,t,J=8.8Hz),4.3
0−4.40(2H,q,J=7.1Hz),4.78
−4.87(1H,m),5.28(2H,bs),
7,13(1H,d,J=7.8Hz),7,30−
7.43(6H,m),7.60−7.67(2H,
m),7.74(1H,d,J=7.8Hz),7.8
9(1H,d,J=7.8Hz),8.12(1H,b
s),8.96(1H,bs)
【0173】
【参考例34】N−(インドリン−5−カルボニル)−γ−(3−エト
キシカルボニルアニリド)−L−グルタミン酸α−メチ
ルエステルの合成
【0174】参考例33.の化合物(842mg)のメ
タノール溶液(11ml)に10%パラジウム−炭素
(0.17g)を加えた後、水素雰囲気下、室温で15
時間攪拌した。セライトを用いてパラジウム−炭素を濾
去し、減圧下で溶媒を留去した。得られた残渣をシリカ
ゲルクロマトグラフィーに付し、溶出溶媒としてクロロ
ホルム、次いでクロロホルム:メタノール=99:1を
用いて目的物(448mg)を得た。
【0175】1H−NMR(CDCl3,δ):1.3
6(3H,t,J=7.1Hz),2.05−2.25
(1H,m),2.25−2.48(1H,m),2.
25−2.48(2H,m),2.93(2H,t,J
=8.8Hz),3.57(2H,t,J=8.8H
z),3.71(3H,s),4.18(1H,b
s),4.34(2H,t,q,J=7.1Hz),
4.73−4.84(1H,m),6.46(1H,
d,J=8.8Hz),7.16(1H,d,J=7.
8Hz),7.32(1H,t,J=7.8Hz),
7.50−7.53(2H,m),7.73(1H,
d,J=7.8Hz),7.87(1H,d,J=7.
3Hz),8.19(1H,s),9.39(1H,b
s)
【0176】
【実施例17】N−[1−[(2,4−ジアミノ−6−プテリジニル)
メチル]−インドリン−5−カルボニル]−γ−(3−
エトキシカルボニルアニリド)−L−グルタミン酸α−
メチルエステルの合成
【0177】参考例34.の化合物(448mg)と6
−ブロモメチル−2,4−ジアミノプテリジン臭化水素
酸塩イソプロパノール付加物(587mg)をジメチル
アセトアミド(5ml)に懸濁させ、室温で36時間攪
拌した。反応液をシリカゲルクロマトグラフィーに付
し、溶出溶媒として酢酸エチル、次いでクロロホルム:
メタノール=9:1を用いて目的物(653mg)を得
た。
【0178】1H−NMR(DMSO−d6,δ):
1.34(3H,t,J=6.8Hz),1.96−
2.32(2H,m),2.32−2.59(2H,
m),3.00(2H,t,J=7.3Hz),3.5
6−3.66(5H,s),4.32(2H,q,J=
6.5Hz),4.40−4.56(3H,m),6.
66−6.71(3H,bs),7.39(1H,t,
J=7.8Hz),7.63−7.67(3H,m),
7.84(1H,d,J=7.3Hz),8.22(1
H,s),8.32(1H,d,J=7.3Hz),
8.73(1H,s),10.11(1H,s)
【0179】
【実施例18】N−[1−[(2,4−ジアミノ−6−プテリジニル)
メチル]−インドリン−5−カルボニル]−γ−(3−
カルボキシアニリド)−L−グルタミン酸の合成
【0180】実施例17.の化合物(303mg)をメ
タノール(10ml)に溶解し、1N−水酸化ナトリウ
ム水溶液(1.06ml)を加え、室温で12時間攪拌
した。水(1ml)を加え、さらに2時間攪拌した。水
浴の温度を30℃以下に保ちながら減圧下で溶媒を留去
した。得られた残渣を飽和炭酸水素ナトリウム水溶液に
溶解し、1N−塩酸を用いてpH=3.7に調整した。
析出した橙色沈澱物を濾取し、目的物(157mg)を
得た。
【0181】1H−NMR(DMSO−d6,δ):
1.97−2.25(2H,m),2.42−2.58
(2H,m),2.99(2H,t,J=8.8H
z),3.59(2H,t,J=8.8Hz),4.3
3−4.45(1H,m),4.59(2H,s),
6.71(1H,d,J=8.3Hz),6.93(2
H,bs),7.39(1H,t,J=7.8Hz),
7.57−7.82(5H,m),7.88−8.04
(1H,m),8.06−8.12(1H,m),8.
15−8.26(2H,m),8.75(1H,s),
10.12(1H,s)
【0182】
【参考例35】N−カルボベンゾキシ−γ−N′,N′−ジメチルアミ
ド−L−グルタミン酸α−ベンジルエステルの合成
【0183】N−カルボベンゾキシ−L−グルタミン酸
α−ベンジルエステル(508mg)とトリエチルアミ
ン(0.19ml)のテトラヒドロフラン溶液(2m
l)に、−20℃、窒素雰囲気下、クロル炭酸エチル
(0.14ml)を加え30分攪拌した。次いで、ジメ
チル塩酸塩(112mg)とトリエチルアミン(0.1
9ml)のジクロロメタン溶液(3ml)を加えた後、
1時間攪拌した。徐々に室温に戻し、さらに24時間攪
拌した。減圧下で溶媒を留去し、得られた残渣をクロロ
ホルムに溶解した。クロロホルム層を飽和炭酸水素ナト
リウム溶液、1N−塩酸で洗浄し、硫酸ナトリウムで乾
燥した後、減圧下で溶媒を留去した。得られた残渣をシ
リカゲルクロマトグラフィーに付し、溶出溶媒としてク
ロロホルム:メタノール=49:1を用いて目的物(4
53mg)を得た。
【0184】1H−NMR(CDCl3,δ):1.9
7−2.37(4H,m),2.86(3H,s),
2.90(3H,s),4.39−4.41(1H,
m),5.10(2H,s),5.17(2H,s),
5.86−5.89(1H,m),7.34(10H,
s)
【0185】
【参考例36】N−カルボベンゾキシ−γ−N′,N′−ジメチルアミ
ド−L−グルタミン酸の合成
【0186】参考例35.の化合物(450mg)のメ
タノール溶液(5ml)に、1N−水酸化ナトリウム水
溶液(1.15ml)を加え、室温で一晩攪拌した。水
浴の温度を30℃以下に保ちながら減圧下で溶媒を留去
した。得られた残渣を水に溶解し、1N−塩酸で酸性し
たところでクロロホルムを用いて抽出した。クロロホル
ム層を硫酸ナトリウムで乾燥した後、減圧下で溶媒を留
去し、目的物(341mg)を得た。
【0187】1H−NMR(CDCl3,δ):1.9
3−2.06(1H,m),2.21−2.33(1
H,m),2.42−2.56(1H,m),2.76
−2.84(1H,m),2.98(3H,s),3.
00(3H,s),4.19−4.27(1H,m),
5.09(2H,s),6.04−6.06(1H,
m),7.37(10H,s)
【0188】
【参考例37】N−カルボベンゾキシ−γ−N′,N′−ジメチルアミ
ド−L−グルタミン酸α−メチルエステルの合成
【0189】参考例36.の化合物(353mg)を乾
燥メタノール(4ml)に溶解し、トリメチルシリルジ
アゾメタン(5ml)を加え、2時間攪拌した。減圧下
で溶媒を留去し、目的物(338mg)を得た。
【0190】1H−NMR(CDCl3,δ):1.9
6−2.43(4H,m),2.92−(3H,s),
2.95(3H,s),3.74(3H,s),4.2
8−4.40(1H,m),5.10(2H,s),
5.80(1H,m),7.35(5H,s)
【0191】
【参考例38】γ−N′,N′−ジメチルアミド−L−グルタミン酸α
−メチルエステルの合成
【0192】参考例37.の化合物(580mg)をメ
タノール溶液(10ml)に10%パラジウムー炭素
(70mg)を加えた後、水素雰囲気下、室温で15時
間攪拌した。セライトを用いてパラジウム−炭素を濾去
し、減圧下で溶媒を留去した。得られた残渣をシリカゲ
ルクロマトグラフィーに付し、溶出溶媒としてクロロホ
ルム:メタノール=19:1を用いて目的物(160m
g)を得た。
【0193】1H−NMR(CDCl3,δ):1.7
4−1.92(1H,m),2.06−2.23(1
H,m),2.47(2H,t,J=7.3Hz),
2.95(3H,s),3.02(3H,s),3.4
9−3.56(1H,m),3.73(3H,s)
【0194】
【参考例39】N−(1−カルボベンゾキシインドリン−5−カルボニ
ル)−γ−N′,N′−ジメチルアミド−L−グルタミ
ン酸α−メチルエステルの合成
【0195】1−カルボベンゾキシインドリン−5−カ
ルボン酸(295mg)に塩化チオニル(2ml)を加
え室温で2時間攪拌した。次に反応液を減圧下で濃縮乾
固した。得られた固形物をジクロロメタン(2ml)に
溶解させ、この溶液に、参考例38.の化合物(160
mg)とトリエチルアミン(0.18ml)のジクロロ
メタン溶液(2.5ml)を氷冷、窒素雰囲気下で加え
一晩攪拌した。反応液を1N−塩酸、飽和炭酸水素ナト
リウム水溶液、水で順次洗浄し、硫酸ナトリウムで乾燥
した後、減圧下で溶媒を留去した。得られた残渣をシリ
カゲルクロマトグラフィーに付し、溶出溶媒としてクロ
ロホルム、次いでクロロホルム:メタノール=99:1
を用いて目的物(359mg)を得た。
【0196】1H−NMR(CDCl3,δ):2.2
2−2.32(2H,m),2.43−2.55(2
H,m),2.94(3H,s),2.98(3H,
s),3.15(2H,t,J=8.8Hz),3.7
6(3H,s),4.10(2H,t,J=8.8H
z),4.58−4.68(1H,m),5.28(2
H,s),7.36−7.41(6H,m),7.71
(1H,s),7.90(1H,d,J=5.9Hz)
【0197】
【参考例40】N−(インドリン−5−カルボニル)−γ−N′,N′
−ジメチルアミド−L−グルタミン酸α−メチルエステ
ルの合成
【0198】参考例39.の化合物(359mg)のメ
タノール溶液(5ml)に10%パラジウム−炭素(7
0mg)を加えた後、水素雰囲気下室温で15時間攪拌
した。セライトを用いてパラジウム−炭素を濾去し、減
圧下で溶媒を留去した。得られた残渣をシリカゲルクロ
マトグラフィーに付し、溶出溶媒としてクロロホルム:
メタノール=99:1を用いて目的物(131mg)を
得た。
【0199】1H−NMR(CDCl3,δ):2.1
9−2.30(2H,m),2.44−2.53(2
H,m),2.93(3H,s),2.97(3H,
s),3.04(2H,t,J=8.3Hz),3.6
2(2H,t,J=8.3Hz),3.75(3H,
s),4.14(1H,bs),4.60−4.70
(1H,m),6.56(1H,d,J=7.8H
z),7.51−7.62(3H,m)
【0200】
【実施例19】N−[1−[(2,4−ジアミノ−6−プテリジニル)
メチル]−インドリン−5−カルボニル]−γ−N′,
N′−ジメチルアミド−L−グルタミン酸α−メチルエ
ステルの合成
【0201】参考例40.の化合物(131mg)と6
−ブロモメチル−2,4−ジアミノプテリジン臭化水素
酸塩イソプロパノール付加物(233mg)をジメチル
アセトアミド(4ml)に懸濁させ、室温で24時間攪
拌した。反応液をシリカゲルクロマトグラフィーに付
し、溶出溶媒として酢酸エチル、次いでクロロホルム:
メタノール=9:1を用いて目的物(95mg)を得
た。
【0202】1H−NMR(CDCl3,δ):1.9
8−2.17(2H,m),2,42(2H,t,J=
6.8Hz),2.84(3H,s),2.94(3
H,s),3.00(2H,t,J=8.3Hz),
3.59(2H,t,J=8.3Hz),3.64(3
H,s),4.30−4.42(1H,m),4.55
(2H,s),6.68(1H,d,J=7.3H
z),7.60−7.64(2H,m),8.34(1
H,d,J=7.3Hz),8.71(1H,s)
【0203】
【実施例20】
N−[1−[(2,4−ジアミノ−6−ブテリジニル)
メチル]−インドリン−5−カルボニル]−γ−N′,
N′ージメチルアミド−L−グルタミン酸の合成
【0204】実施例19.の化合物(70mg)をメタ
ノール(5ml)に溶解し、1N−水酸化ナトリウム水
溶液(0.15ml)を加え、室温で12時間攪拌し
た。水(2ml)を加え、さらに5時間攪拌した。水浴
の温度を30℃以下に保ちながら減圧下で溶媒を留去し
た。得られた残渣を飽和炭酸水素ナトリウム水溶液に溶
解し、1N−塩酸を用いてpH=3.7に調整した。折
出した橙色沈澱物を濾取し、目的物(16mg)を得
た。
【0205】1H−NMR(DMSO−d6,δ):
1.96−2.08(2H,m),2.41(2H,
t,J=7.1Hz),2.82(3H,s),2.9
2(3H,s),3.01(2H,t,J=7.8H
z),3.62(2H,t,J=7.8Hz),4.2
7−4.37(1H,m),4.62(2H,s),
6.72(1H,d,J=8.8Hz),7.61−
7.64(2H,m),8.24(1H,d,J=6.
8Hz),8.87(1H,s),12.46(1H,
bs)
【0206】
【参考例41】N−1−[(2,4−ジアミノ−6−プテリジニル)メ
チル]1,2,3,4−テトラハイドロ−6−キノリン
カルボン酸の合成
【0207】6−ブロモメチル−2,4−ジアミノプテ
リジン臭化水素酸塩・イソプロパノール付加物(178
mg)と1,2,3,4−テトラハイドロ−6−キノリ
ンカルボン酸(55mg)をジメチルアセトアミド(3
ml)に懸濁し、60〜65℃で一夜攪拌した。冷却後
反応液に水(10ml)を加え、氷−水冷却下、反応液
を1N−塩酸でpH=3.5に調整し、冷所で一夜放置
した。析出した沈殿物を濾取し、目的物(70mg)を
得た。
【0208】1H−NMR(DMSO−d6,δ):
2.08(2H,t,J=8Hz),2.88(2H,
t,J=8Hz),3.68(2H,t,J=8H
z),4.72(2H,s),6.62(1H,d,J
=9Hz),7.48(2H,m),8.51(1H,
s)
【0209】
【実施例21】N−1−[(2,4−ジアミノ−6−プテリジニル)メ
チル]1,2,3,4−テトラハイドロ−6−キノリン
カルボニル]−L−グルタミン酸ジエチルの合成
【0210】トリエチルアミン(60mg)とジエチル
ホスホロシアニデート(98mg)を無水ジメチルホル
ムアミド(6ml)に懸濁し、さらに、参考例41.の
化合物(60mg)を加え攪拌した。溶解した後、反応
液を80℃で3分間攪拌し、更に室温に戻して10分間
攪拌した。次いでトリエチルアミン(20mg)とグル
タミン酸ジエチルエステル塩酸塩(40mg)を加え、
80℃で2時間攪拌した。反応後溶媒を減圧にて留去
し、残渣にクロロホルムを加え、クロロホルム層を飽和
重曹水で洗浄した。クロロホルム層を硫酸マグネシウム
で乾燥後、減圧で溶媒を留去し、得られた残渣をシリカ
ゲルカラムクロマトグラフィーに付し、溶出溶媒として
クロロホルム:メタノール=10:1の混合溶媒を用い
目的物(50mg)を得た。
【0211】1H−NMR(DMSO−d6,δ):
1.1−1.4(6H,m),1.8−2.4(4H,
m),2.40(2H,t,J=8Hz),2.82
(2H,t,J=8Hz),3.51(2H,t,J=
8Hz),4.0−4.3(4H,m),4.64(1
H,m),4.75(2H,s),6.65(1H,
d,J=3Hz),7.47(2H,m),8.65
(2H,s)
【0212】
【実施例22】
N−1−[(2,4−ジアミノ−6−プテリジニル)メ
チル]1,2,3,4−テトラハイドロ−6−キノリン
カルボニル]−L−グルタミン酸の合成
【0213】実施例21.の化合物(50mg)をエタ
ノール(10ml)に溶解L、35℃で1N−水酸化ナ
トリウム水溶液(0.24ml)を加え、同温度で4.
5時間撹拌した。更に、25℃で20時間攪拌を続けた
後、反応液に水(1ml)を加えた。氷−水冷却下、反
応液を1N−塩酸でpH=3.7に調整し、冷所で一夜
放置した。析出した沈殿物を濾取し、目的物(27m
g)を得た。
【0214】1H=NMR(DMSO−d6,δ):
1.8−2.2(4H,m),2.31(2H,t,J
=8Hz),2.75(2H,t,J=8Hz),3.
60(2H,t,J=8Hz),4.36(1H,
m),4.70(2H,s),6.62(1H,d,J
=9Hz),7.51(2H,m),8.62(1H,
s)
mp;204−208℃(dec.)
【0215】
【参考例42】4−[(2,4−ジアミノ−6−プテリジニル)メチ
ル]−3,4−ジヒドロ−2H−1,4−ベンゾオキサ
ジン−7−カルボン酸メチルの合成
【0216】6−ブロモメチル−2,4−ジアミノプテ
リジン臭化水素酸塩・イソプロパノール付加物(410
mg)と3,4−ジヒドロ−2H−1,4−ベンゾオキ
サジン−7−カルボン酸メチル(200mg)をジメチ
ルアセトアミド(10ml)に懸濁し、浴温65℃で4
時間、90℃で19時間攪拌した。冷却後、ジメチルア
セトアミドを減圧下濃縮し、クロロホルムと炭酸水素ナ
トリウム水溶液を加えた。析出物を濾去した後、有機層
を水洗、硫酸マグネシウムで乾燥後、溶媒を減圧下留去
した。残査をシリカゲルカラムクロマトグラフィーに付
し、クロロホルム:メタノール=97:3の混合溶媒で
溶出して、目的物(100mg)を得た。
【0217】1H−NMR(CDCl3:CD3OD=
9:1,δ):3.63(2H,brt),3.84
(3H,s),4.32(2H,brt),4.72
(2H,s),6.68(1H,d,J=9.0H
z),7.47(1H,s),7.50(1H,d,J
=9.0Hz),8.71(1H,s)
【0218】
【参考例43】4−[(2,4−ジアミノ−6−プテリジニル)メチ
ル]−3,4−ジヒドロ−2H−1,4−ベンゾオキサ
ジン−7−カルボン酸の合成
【0219】参考例42.の化合物(60mg)を1N
−水酸化ナトリウム水溶液(20ml)とメタノール
(20ml)の混合溶媒に懸濁し、2.5時間加熱還流
した。冷却後、溶媒を留去し水を加え、1N−塩酸でp
H=5(懸濁した)に調整した。冷所に一晩放置後、濾
取し、乾燥して目的物(60.8mg)を得た。
【0220】1H−NMR(DMSO−d6,δ):
3.63(2H,m),4.22(2H,m),4.7
1(2H,s),7.21(1H,s),8.29(1
H,s)
【0221】
【実施例23】N−[4−[(2,4−ジアミノ−6−プテリジニル)
メチル]−3,4−ジヒドロ−2H−1,4−ベンゾオ
キサジン−7−カルボニル]−L−グルタミン酸ジエチ
ルの合成
【0222】ジフェニルホスホロシアニデート(64μ
l)、トリエチルアミン(60μl)、乾燥ジメチルホ
ルムアミド(5ml)の溶液に参考例43.の化合物
(50mg)を加え、窒素雰囲気下、80℃で5分撹拌
した。室温まで冷却し、トリエチルアミン(20μl)
とグルタミン酸ジエチル(34mg)を加え、再び80
℃に加熱し、2.5時間撹拌した。冷却後、クロロホル
ムで抽出し、炭酸水素ナトリウム水溶液、食塩水で洗浄
した。硫酸マグネシウムで乾燥後、溶媒を留去した。残
渣をシリカゲルカラムクロマトグラフィーに付し、クロ
ロホルム:メタノール=19:1の混合溶媒にて溶出し
て、目的物(10mg)を得た。
【0223】1H−NMR(CDCl3:CD3OD=
9:1,δ):1.23(3H,t,J=6.8H
z),1.29(3H,t,J=6.8Hz),3.6
0(2H,m),4.11(2H,q,J=6.8H
z),4.22(2H,q,J=6.8Hz),4.3
2(2H,m),4.71(2H,s),6,69(1
H,d,J=10.0Hz),7.29(1H,d,J
=10.0Hz),7.36(1H,z),8.70
(1H,s)
【0224】
【実施例24】N−[4−[(2,4−ジアミノ−6−プテリジニル)
メチル]−3,4−ジヒドロ−2H−1,4−ベンゾオ
キサジン−7−カルボニル]−L−グルタミン酸の合成
【0225】実施例23.の化合物(9mg)をエタノ
ール(3ml)に溶解し、1N−水酸化ナトリウム水溶
液を加えて、室温で4日間撹拌した。溶媒を留去し、シ
リカゲルカラムクロマトグラフィーに付し、クロロホル
ム:メタノール:アンモニア水=5:4:1の混合溶媒
にて溶出し、目的物を含有するフラクションを集めて、
溶媒を留去した。飽和炭酸水素ナトリウム水溶液(20
0μl)を加えて溶解して、1N−塩酸を滴下してpH
を約4(懸濁した)に調整し、冷所に一晩放置した。析
出物を濾取して乾燥し、目的物(2.8mg)を得た。
【0226】1H−NMR(DMSO−d6,δ):
1.86−1.95(1H,m),1.95−2.03
(1H,m),2.24−2.38(2H,m),3.
67(2H,t,J=3.8Hz),4.25(2H,
t,J=3.8Hz),4.30(1H,m),4.7
0(2H,s),6.83(1H,d,J=8.6H
z),7.26(1H,s),7.30(1H,d,J
=8.6Hz),8.09(1H,m),8.70(1
H,s)
IR(KBr)νmax 3464,1642 and
1512cm−1
【0227】DETAILED DESCRIPTION OF THE INVENTION
[0001]
BACKGROUND OF THE INVENTION The present invention relates to a novel methotrexe
Derivatives, and more specifically, novel methods useful as anticancer agents.
It relates to a totrexate derivative.
[0002]
2. Description of the Related Art Methotre
Kisate has been used as a treatment for leukemia since ancient times.
However, in 1951, Gubner et al.
(RA) and its efficacy in psoriasis
It has been used in Europe and the United States as a remedy. Relatively recently
Detailed study of dosage and administration was conducted,
Rexate therapy has relatively few side effects and is excellent
It has proven to be effective. But me
Liver damage and lung fibrosis caused by taking totrexate
Since side effects cannot be ignored, there are fewer side effects.
There is a demand for a drug with excellent efficacy.
[0003] Until now, N10Other than a methyl group
As a methotrexate derivative with a kill group introduced
Is, for example,
Embedded image
(J. Med. Chem.,22, 862 (197)
9)) and expressions
Embedded image
(J. Med. Chem.,25, 877 (198
2)) etc. are known, but those showing satisfactory activity
Did not.
[0004] We have discovered that this type of methotrexate
In search of compounds with superior anticancer action in derivatives
After intensive research, the present invention has been accomplished.
[0005]
According to the present invention, there is provided a compound represented by the following general formula:
(I)
Embedded image
Where R1Is CH2, CH2CH2, CH2O, CH2
S, CH2SO, CH2SO2And CH2Composed of NH
R represents a member selected from the group:2Is a hydrogen atom or charcoal
Represents a lower alkyl group having a prime number of 1 to 4;
R represents an integer;3Is the general formula COOR4(Where R4
Represents a hydrogen atom or a lower alkyl group having 1 to 4 carbon atoms.
) Or the general formula NHCOR5(Where R5Is replaced
Or a phenyl group which may be represented by the general formula CONR
6R7(Where R6Is a hydrogen atom or a group having 1 to 4 carbon atoms
R represents a lower alkyl group;7Represents a lower alkyl group having 1 to 4 carbon atoms.
Represents an alkyl group or an optionally substituted phenyl group.
Or PO3H2, SO3A group represented by H;
To provide a methotrexate derivative represented by
You.
[0006] The compounds of the present invention are all new
It is a reference compound and is synthesized, for example, as follows.
(Method A)
Embedded image(Method B)
Embedded image(Method C) R in the general formula (I)3Is the general formula
Embedded image
(R ′: hydrogen atom or lower alkyl having 1 to 4 carbon atoms)
Base)
Embedded image (Where R1, R2, R3And n have the same meaning as above
R ′ is a hydrogen atom or a lower alkyl having 1 to 4 carbon atoms.
A kill group;1And A2Represents a protecting group, and X represents
Indicates a logen atom. )
In the method A, the compound of the general formula (1)
The reaction for obtaining the compound of the general formula (2) from the compound of the general formula (1)
The compound is converted to an acid halo such as thionyl chloride, oxalyl chloride, etc.
Suspended in a gentizing agent, and a catalytic amount of dimethylformamide
It is performed by stirring at room temperature in the coexistence. Where A1so
The protecting groups shown include carbobenzoxy group, tosyl
Group, acetyl group and the like.
The compound of the general formula (2) and the compound of the general formula (3)
The reaction for obtaining the compound of the general formula (4) from the compound is represented by the general formula
Compound (2) dissolved in a solvent such as dichloromethane
The water of the compound of the general formula (3) is cooled under ice-cooling or water-cooling.
In addition to the solution, potassium carbonate, sodium hydroxide, carbonated water
Stir at room temperature in the presence of an inorganic base such as sodium hydrogen
And so on.
The compound of the general formula (4) is converted from the compound of the general formula (5)
The reaction to obtain the compound is bromination of anisole and phenol.
Compound of general formula (4) in a solution dissolved in hydrogen-acetic acid solution
And stirring at 10 ° C to 60 ° C, preferably at room temperature
Performed by Further, from the compound of the general formula (4),
The reaction for obtaining the compound of the formula (5) is carried out by reacting the compound of the general formula (4)
Dissolve in a solvent such as methanol, ethanol, acetic acid, etc.
After adding radium-carbon, stir at room temperature under hydrogen atmosphere
May be performed.
The compound of the general formula (6) and the compound of the general formula (5)
The reaction for obtaining the compound of the general formula (7) from the compound is performed by the general formula
The compound of (6) and the compound of general formula (5) are dimethylacetate
0 ° C to 1 in a solvent such as toamide and dimethylformamide
The stirring is carried out at 00 ° C, preferably at 50 ° C to 60 ° C. In particular
R2Is a hydrogen atom, methanol or ethanol
To a solvent such as ethanol.
The desired product is stirred at 0 ° C to 60 ° C, preferably at 35 ° C.
obtain. In the formula, the halogen atom represented by X is bromine
Atom, chlorine atom and the like.
In the method B, the compound of the general formula (6)
A compound of the general formula (9) is obtained from a compound of the general formula (8)
The reaction is carried out by reacting the compound of the general formula (6) with the compound of the general formula (8)
With dimethylacetamide or dimethylformamide
Stir at 0 ° C to 100 ° C, preferably 55 ° C in a medium
Performed by
The compound of the general formula (9) and the compound of the general formula (3)
The reaction for obtaining the compound of the general formula (7) from the compound is performed by the general formula
The compound of (9) is used as
Hexylcarbodiimide and 1-hydroxybenzotria
Dimethylformamide, dimethyla
Stir in a solvent such as Cetamide, N-methylpyrrolidinone, etc.
After that, the compound of the general formula (3) is added, and 0 ° C to 200 ° C is added.
It is preferably performed by stirring at 10 ° C to 80 ° C. Special
To R2Is a hydrogen atom, methanol or ethanol
Add a 1N sodium hydroxide solution in a solvent such as
And stirring at 0 ° C to 60 ° C, preferably at room temperature to obtain the desired product
You.
In the method C, the compound of the general formula (10)
And a compound of the general formula (12) from the compound of the formula (11)
The reaction is performed by converting the compound of the general formula (10) into chloroform and
Non-chloromethane, tetrahydrofuran, dioxane, etc.
Dissolve in a protic solvent and add the compound of formula (11) and water
For example, potassium carbonate, triethylamine, sodium hydrogen carbonate
And pyridine, etc., and stirred at room temperature.
U. Where A2As the protecting group represented by, carboben
Examples include a zoxy group, a tosyl group, and an acetyl group.
From the compound of the general formula (12), the compound of the general formula (1)
The reaction for obtaining the compound of 3) is carried out in a solvent such as methanol,
The mixture is stirred at 60 ° C to -20 ° C, preferably at -30 ° C.
It is carried out by refluxing after adding onyl.
From the compound of the general formula (13), the compound of the general formula (1)
The reaction for obtaining the compound of 4) is carried out by reacting the compound of general formula (13)
Ethanol, methanol, tetrahydrofuran, diox
Dissolve in sun, etc., and in a hydrogen atmosphere in the presence of palladium-carbon
It is performed by stirring at room temperature under air.
The compound of the general formula (14) and the compound of the general formula (2)
The reaction for obtaining the compound of the general formula (15) from the compound is carried out by the general
The compound of the formula (2) is dissolved in dichloromethane or the like.
Dissolve the compound of general formula (14) with potassium carbonate or
Add ethylamine and water and stir at room temperature
Perform the mixed anhydride method, active ester or active
The amidation may be carried out by the amide method.
From the compound of the general formula (15), the compound of the general formula (1)
The reaction for obtaining the compound of 6) is carried out by reacting the compound of general formula (15)
Dissolve phenol or anisole in advance
Hydrogen bromide-acetic acid was added and stirred at room temperature.
U.
The compound of the general formula (6) and the compound of the general formula (16)
The reaction for obtaining the compound of the general formula (17) from the compound is a
Such as tilacetamide and dimethylformamide
25 ° C. to 100 ° C., preferably 5 ° C. in an aprotic polar solvent
After stirring at 0 ° C. to 65 ° C., for example, triethylamine,
In water containing potassium carbonate or sodium hydrogen carbonate
This is performed by stirring.
From the compound of the general formula (17), the compound of the general formula (I)
The reaction to obtain the compound of
Add sodium solution and stir at room temperature.
[0020]
The compound represented by the general formula (I) obtained by the present invention.
The compounds have an anticancer effect. This effect is demonstrated in the following experiment
Example: Confirmed by conducting a mouse cancer cell growth inhibition experiment
did.
"Mouse cancer cell growth inhibition experiment (cancer
for)"
(Method)
RPMI 1640 medium (fetal bovine serum 5
%, 2-mercaptoethanol in 10-6To be M
Mouse phosphorus suspended in
Oplasma P388 cells or mouse colon
26 carcinoma cells were transferred to a flat bottom microplate (Co
5 × 10 in each well of # 25870)
3Drug solution prepared in the same medium
Was added so that each well was 0.2 ml. This
This was placed in a carbon dioxide cultivation apparatus (carbon dioxide 5%, air 95%, wet
After culturing for 3 days in the MTT solution (3-%
(4,5-dimethylthiazol-2-yl) -2,5-
Diphenyltetrazolium bromide in phosphate buffered physiology
5 mg / ml with a common saline solution (pH 7.4, 10 mM).
Was added to each well in an amount of 10 μl.
After further culturing for 4 hours, the culture supernatant was
The resulting dye (formazan) is removed by D
MSO (dimethyl sulfoxide; 150 μl / well
) And absorb with a microplate spectrophotometer.
The degree (540 nm) was measured.
The drugs used are as follows.
Embedded image
(Results and Discussion) Using P388 cells in FIG.
Example of the case where colon 26 is used in FIG. 2
showed that. Data are for wells with no drug added
Cell proliferation, that is, the absorbance is set to 100%, and the drug is added.
To which extent growth was suppressed
Is shown in%.
As is apparent from FIG. 1 and FIG.
Ming's compound has better inhibitory effect on cancer cell growth than control drug
(Carcinostatic action).
[0026]
【Example】
[Reference Example 1]Synthesis of 1-carbobenzoxy-5-carboxyindoline
Success
5-carboxyindoline (2.0 g)
Sodium hydroxide (0.6g) was added to water (20ml)
After adding to a mixture of chill ether (20 ml), ice-water
Under cooling, carbobenzoxycyclolide (2.59 g) and water
Sodium oxide (2.1 g) was added and water (10 ml) was exchanged.
They were added to each other and stirred at room temperature for 2 hours. Reaction solution is 2N-salt
The mixture was acidified with an acid, and the precipitated crystals were filtered. Wash with ether
After the purification, the product was air-dried to obtain the desired product (2.8 g).
[0028]1H-NMR (DMSO-d6, Δ):
3.10 (2H, t, J = 8 Hz), 4.03 (2H,
t, J = 8 Hz), 5.23 (2H, s), 7.2-
8.0 (8H, m)
mp; 194-196 <0> C
[0029]
[Reference Example 2]N- (1-carbobenzoxyindoline-5-carboni
G) Synthesis of diethyl-L-glutamate
Reference Example 1 Compound (2.5 g)
After suspension in onil (10 ml), a catalytic amount of dimethylform
The amide was added and stirred at room temperature for 30 minutes. Then under reduced pressure
The excess thionyl chloride is distilled off, and the residue is washed with N-hexane.
Triturated. After filtering the obtained crystals,
Dissolve in dichloromethane (20 ml) and add this dichloromethane
Glutamic acid diethyl ester hydrochloride under ice-water cooling
Contains salt (3.0 g) and triethylamine (2.8 g)
It was added dropwise to a dichloromethane (50 ml) suspension. At room temperature
After stirring for 2.5 hours, the solvent was distilled off under reduced pressure.
Under ice-water cooling, ethyl acetate (200 ml) and dilute hydrochloric acid (2
00 ml). After stirring for 5 minutes, organic
The layers were separated. Wash the organic layer with 5% aqueous sodium carbonate solution
After cleaning, it was dried with magnesium sulfate. Then ethyl acetate
Is distilled off under reduced pressure, and the obtained residue is
Chromatography and chloroform
Using a mixed solvent of methanol: methanol = 30: 1,
(3.1 g) was obtained.
[0031]1H-NMR (CDCl3, Δ): 1.1
9 (3H, t, J = 7 Hz), 1.25 (3H, t, J)
= 7 Hz), 2.1-2.6 (4H, m), 3.06
(2H, t, J = 8 Hz), 3.8-4.3 (6H,
m), 4.75 (1H, m), 5.20 (2H, s),
6.79 (1H, d, J = 7 Hz), 7.2-7.7
(8H, m)
mp; 120-121 ° C
[0032]
[Reference Example 3]N- (indoline-5-carbonyl) -L-glutamine
Of diethyl methacrylate
Reference Example 2 Compound (1.8 g)
Dissolve in hydrofuran (80 ml) and add 10% palladium
-After adding carbon (0.4 g), at room temperature under hydrogen atmosphere
Stir for 5 hours. Palladium-carbon using celite
The desired product (1.2 g) was obtained by filtration.
[0034]1H-NMR (CDCl3, Δ): 1.2
1 (3H, t, J = 7 Hz), 1.29 (3H, t, J
= 7 Hz), 2.0-2.6 (4H, m), 3.00
(2H, t, J = 8 Hz), 3.59 (2H, t, J =
8 Hz), 4.07 (2H, q, J = 7 Hz), 4.1
9 (2H, q, J = 7 Hz), 4.75 (1H, m),
6.47 (1H, d, J = 9 Hz), 6.68 (1H, d, J = 9 Hz)
d, J = 7 Hz), 7.45 (1H, d, J = 9H)
z), 7.49 (1H, s)
mp; 96-97 ° C
[0035]
Embodiment 1N- [1-[(2,4-diamino-6-pteridinyl)
Methyl] indoline-5-carbonyl] -L-glutami
Synthesis of diethyl phosphate
Reference Example 3 (214 mg) and 6-
Bromomethyl-2,4-diaminopteridine hydrobromic acid
Salt / isopropanol adduct (250 mg) in dimethyl
Suspend in acetamide (3 ml), 4 hours at 50-55 ° C
While stirring. After cooling, triethylamine (12
4 mg) in water (15 ml) and stirred.
Extraction was performed four times with loroform (350 ml). Yes
After drying the organic layer with magnesium sulfate, the solvent was distilled off under reduced pressure.
The residue obtained is separated by silica gel column chromatography.
And eluted with chloroform: methanol
= 10: 1 using a mixed solvent to give the desired product (200 mg)
Obtained.
[0037]1H-NMR (DMSO-d6, Δ):
1.22 (3H, t, J = 7 Hz), 1, 30 (3H,
t, J = 7 Hz), 2.0-2.5 (4H, m), 3.
07 (2H, t, J = 8 Hz), 3.57 (2H, t,
J = 8 Hz), 4.10 (2H, q, J = 7 Hz),
4.23 (2H, q, J = 7 Hz), 4.79 (1H,
m), 5.24 (2H, s), 6.51 (1H, d, J
= 9 Hz), 6.76 (1H, d, J = 7 Hz), 7.
57 (1H, s), 7.59 (1H, d, J, = 9H
z), 8.82 (1H, s)
mp; 168-170 ° C
[0038]
Embodiment 2N- [1-[(2,4-diamino-6-pteridinyl)
Methyl] indolinecarbonyl] -L-glutamic acid
Synthesis of (Compound 1)
Embodiment 1 Compound (170 mg)
Dissolved in ethanol (33 ml) at 35 ° C with 1N sodium hydroxide
An aqueous solution of lithium (0.84 ml) was added, and the mixture was heated at the same temperature for 4.5 hours.
Stirred for hours. After further stirring at 25 ° C. for 20 hours,
Water (2 ml) was added to the reaction solution. Reaction solution under ice-water cooling
Was adjusted to pH = 3.7 with 1N-hydrochloric acid and left overnight in a cool place
did. The deposited precipitate was collected by filtration and the desired product (130 mg)
I got
[0040]1H-NMR (DMSO-d6, Δ):
1.94 (2H, m), 2.32 (2H, m), 2.9
8 (2H, t, J = 8 Hz), 3.56 (2H, t, J
= 8 Hz), 4.29 (1H, m), 4.53 (2H,
s), 6.71 (1H, d, J = 9 Hz), 7.57
(1H, s), 7.59 (1H, d, J = 9 Hz),
8.72 (1H, s)
mp; 201-204 ° C (dec.)
[0041]
[Reference Example 4]N- (1-carbobenzoxyindolin-5-carboni
L) Synthesis of dimethyl-L-α-aminoadipate
1-carbobenzoxyindoline-5-ca
Rubonic acid (3.1 mg) in thionyl chloride (10 ml)
After suspension, add a catalytic amount of dimethylformamide and
Stir for 2 hours. The excess thionyl chloride is then removed under reduced pressure.
The residue was triturated with n-hexane. Profit
After filtering the obtained crystals, dichloromethane (30 ml) was used.
And dissolved in dichloromethane under ice-water cooling.
Including α-aminoadipate dimethylhydrochloride group (2.7 g)
The mixture was added dropwise with an aqueous solution (30 ml). Furthermore, this reaction
Potassium carbonate (5.8 g) was added to the solution. At room temperature,
After stirring overnight, convert the reaction mixture to saturated sodium bicarbonate solution.
The organic matter was extracted with chloroform. Chloroform
The layer was washed with 1N hydrochloric acid, dried over sodium sulfate and reduced.
The solvent was distilled off under pressure. The residue obtained is silica gel
Chromatography, and use chloroform as the elution solvent.
Using a mixed solvent of lum: methanol = 100: 1
(3.1 mg) was obtained.
[0043]1H-NMR (CDCl3, Δ): 1.6.
−2.1 (4H, m), 2.36 (2H, t, J = 6.
8Hz), 3.13 (2H, m), 3.66 (3H,
s), 3.77 (3H, s), 4.09 (2H, m),
4.78 (1H, m), 5.27 (2H, bs), 6.
80 (1H, d, J = 7.8 Hz), 7.2-7.5
(6H, m), 7.63 (2H, m)
[0044]
[Reference Example 5]N- (indoline-5-carbonyl) -L-α-amino
Synthesis of dimethyl adipate
Anisole (1.5 g) 30% hydrogen bromide
-Reference Example 4 in acetic acid (15 ml) solution. Compound (1.5
g) was added and stirred at room temperature for 4 hours. Then, add
A reddish-brown oil precipitated upon addition of an amount of ether.
Was. Remove the oily substance from chloroform by removing most of the ether layer.
Suspended in saturated sodium bicarbonate solution
And the chloroform layer was separated. Chloroform layer
Was dried over sodium sulfate, and the solvent was distilled off under reduced pressure.
Target (960 mg) was obtained.
[0046]1H-NMR (CDCl3, Δ): 1.6.
−2.1 (4H, m), 2.36 (2H, t, J = 6.
8Hz), 3.07 (2H, m), 3.66 (2H,
m), 3.66 (3H, s), 3.77 (2H, s),
4.78 (1H, m), 6.62 (2H, m), 7.5
4 (2H, m)
[0047]
Embodiment 3N- [1-[(2,4-diamino-6-pteridinyl)
Methyl] -indoline-5-carbonyl] -L-α-a
Synthesis of dimethyl minoadipate
Reference Example 5 (960 mg) and 6-
Bromomethyl-2,4-diaminopteridine hydrobromic acid
Salt and isopropanol adduct (1140 mg)
Suspend in luacetamide (20 ml) and at 50-60 ° C
Stir for 6 hours. After cooling, saturated sodium bicarbonate solution
And extract the target substance in three portions with chloroform.
Was. After drying the organic layer over sodium sulfate, the solvent was removed under reduced pressure.
The residue obtained is distilled off and the resulting residue is purified by silica gel column chromatography.
And then eluted with chloroform: methanol
(100m) using a mixed solvent of 100: 10
g) was obtained.
[0049]1H-NMR (CDCl3, Δ): 1.6.
−2.1 (4H, m), 2.38 (2H, t, J = 6.
8Hz), 3.07 (2H, m), 3.57 (2H,
m), 3.67 (3H, s), 3.78 (3H, s),
4.53 (2H, s), 4.74 (1H, m), 6.5
2 (1H, d, J = 8.3 Hz), 7.01 (1H, d, J = 8.3 Hz)
d, J = 7.8 Hz), 7.57 (2H, m), 8.7
7 (1H, s)
[0050]
Embodiment 4N- [1-[(2,4-diamino-6-pteridinyl)
Methyl] -indoline-5-carbonyl] -L-α-a
Synthesis of minoadipic acid
Embodiment 3 FIG. Compound (400 mg)
Dissolved in ethanol (22 ml) and 1N-hydroxide at 35 ° C.
An aqueous solution of thorium (3.1 ml) is added, and the same temperature is applied for 4 hours.
Stirred. After further stirring at 25 ° C. for 20 hours,
Water (3 ml) was added to the reaction solution, and the reaction solution was separated under reduced pressure.
To dryness. At this time, make sure that the outside temperature does not exceed 30 ° C.
Was. The resulting yellow solid was dissolved in water (10 ml) and 1
Adjust the pH to 3.7 with N-hydrochloric acid and place in refrigerator for 2 hours
I left it. The deposited precipitate was collected by filtration, and the desired product (320 m
g) was obtained.
[0052]1H-NMR (CDCl3, Δ): 1.4.
-1.9 (4H, m), 2.23 (2H, t, J = 6.
8Hz), 3.01 (2H, m), 3.58 (2H,
m), 4.32 (1H, m), 4.55 (2H, s),
6.69 (1H, d, J = 8.3 Hz), 7.63 (2
H, m), 8.10 (1H, d, J = 8.3 Hz),
8.72 (1H, s)
[0053]
[Reference Example 6]Nα- (1-carbobenzoxyindoline-5-carbo
Nyl) -Nδ-benzoyl-L-ornithine methyl
Steal Synthesis
1-carbobenzoxyindoline-5-ca
Thionyl chloride (1.5 ml) in rubonic acid (180 mg)
To make a suspension, and add a catalytic amount of
Tilformamide was added and the mixture was stirred at room temperature for 2 hours. Next
The reaction mixture was concentrated to dryness under reduced pressure. The resulting solid is
Dissolve in chloromethane (4 ml) and add Nδ-
Benzoyl-L-ornithine methyl ester (150m
g), calcium carbonate (750 mg) and water
(4 ml) was added and stirred vigorously at room temperature for 12 hours. Next
The reaction mixture was poured into water and extracted with chloroform.
The roloform layer is washed with a 1N hydrochloric acid solution and washed with sodium sulfate.
And dried. The solvent was distilled off under reduced pressure, and the obtained residue was
Silica gel chromatography, elution solvent
Using chloroform: methanol = 100: 3
(140 mg).
[0055]1H-NMR (CDCl3, Δ): 1.6.
-2.2 (4H, m), 3.15 (2H, t, J = 8.
8Hz), 3.56 (2H, m), 3.78 (3H,
s), 4.10 (2H, t, J = 8.8 Hz), 4.8
2 (1H, m), 5.27 (2H, s), 6.70 (1
H, m), 6.89 (1H, d, J = 8.8 Hz),
7.20 (8H, m), 7.68 (2H, m), 7.8
0 (2H, m)
[0056]
[Reference Example 7]
Nα- (indoline-5-carbonyl) -Nδ-benzo
Il-L-ornithineSynthesis of methyl ester
Phenol (150 mg) in 30% bromide water
Reference Example 6 in a hydrogen-acetic acid (2 ml) solution. Of the compound (140
mg) and stirred at room temperature for 4 hours. Next, add
A reddish-brown oil precipitated upon addition of an amount of ether.
Was. Remove the oily substance from chloroform by removing most of the ether layer.
Suspended in saturated sodium bicarbonate solution
And extracted with chloroform. Chloroform layer
Dry over sodium sulfate and evaporate the solvent under reduced pressure
(50 mg).
[0058]1H-NMR (CDCl3, Δ): 1.6.
−2.1 (4H, m), 3.02 (2H, t, J = 8.
8Hz), 3.56 (2H, m), 3.62 (2H,
t, J = 8.8 Hz), 3.75 (3H, s), 4.7
9 (1H, m), 6.55 (1H, d, J = 7.8H
z), 6.86 (2H, m), 6.99 (1H, m),
7.1-7.6 (5H, m), 7.82 (2H, m)
[0059]
Embodiment 5Nα- [1-[(2,4-diamino-6-pteridini)
Ru) methyl] -indoline-5-carbonyl] -Nδ-
Synthesis of benzoyl-L-ornithine methyl ester
Reference Example 7 (50 mg) and 6-butane
Lomomethyl-2,4-diaminopteridine hydrobromide
Isopropanol adduct (44 mg)
Suspend in amide (1 ml) and stir at 50-55 ° C for 4 hours
did. After cooling, triethylamine (22 mg) was added to the reaction mixture.
Water (3 ml) containing water and stirring, and then chloroform.
Extracted. After drying the chloroform layer with sodium sulfate,
The solvent was distilled off under reduced pressure, and the resulting residue was
After the chromatography, chloroform:
Using a mixed solvent of methanol = 10: 1, the desired product (34 m
g) was obtained.
[0061]1H-NMR (CDCl3, Δ): 1.6.
-2.2 (4H, m), 3.07 (2H, t, J = 8.
8Hz), 3.50 (2H, m), 3.56 (2H,
t, J = 8.8 Hz), 3.79 (3H, s), 4.5
3 (2H, s), 4.6 (1H, s), 6.52 (1
H, d, J = 8.3 Hz), 7.19 (1H, d, J =
7.6 Hz), 7.45 (3H, m), 7.62 (2
H, m), 7.80 (2H, m), 8.76 (1H,
s)
[0062]
Embodiment 6Nα- [1-[(2,4-diamino-6-pteridini)
Ru) methyl] -indoline-5-carbonyl] -Nδ-
Synthesis of benzoyl-L-ornithine
Embodiment 5 FIG. Compound (34 mg) in ethanol
(5 ml), and further 1N sodium hydroxide
Solution (0.1 ml) and stirred at 35 ° C. for 4.5 hours
did. After stirring at 25 ° C. for 20 hours, water (1 m
l) was added, and the reaction solution was dried under reduced pressure. This and
The outside temperature did not exceed 30 ° C. The yellow solid obtained
The form was dissolved in water (5 ml) and pH = 3 with 1N hydrochloric acid.
7 and left in the refrigerator for 2 hours. Deposited sediment
The residue was collected by filtration to obtain the desired product (26 mg).
[0064]1H-NMR (DMSO-d6, Δ):
1.64 (2H, m), 1.83 (2H, m), 2.9
8 (2H, t, J = 8.3 Hz), 3.57 (2H,
t, J = 8.3 Hz), 4.36 (1H, m), 4.5
3 (2H, s), 6.64 (2H, m), 7.45 (3
H, m), 7.59 (2H, m), 7.82 (2H,
m), 8.12 (1H, d, J = 8.6 Hz), 8.4
3 (1H, m), 8.69 (1H, s)
mp; 179-183 ° C (dec.)
[0065]
[Reference Example 8]N-phthaloyl-N-carbobenzoxy-ornithine
Synthesis of methyl ester
N-carbobenzoxy-L-ornithine
(2.0 g) in dichloromethane (70 ml) solution
Phthalic acid (2.45 g) was added, followed by water (70 m
l), potassium carbonate (1.12 g) was added and the mixture was kept at room temperature for 15 hours.
And stirred. The reaction solution was concentrated under reduced pressure to 60 ml and
The pH was adjusted to 3 with N-hydrochloric acid, and the deposited precipitate was collected by filtration and vacuumed.
Dried. The resulting white solid was washed with low-moisture methanol (8
0 ml), and the solution is cooled to -30 ° C.
Stirred for 0 minutes. Then, at the same temperature, thionyl chloride (2 ml)
Was slowly added dropwise. Return the reaction solution slowly to room temperature.
The mixture was refluxed for another 2 hours. Solvent is distilled off under reduced pressure
The residue obtained was subjected to silica gel chromatography.
And elution solvent: chloroform: methanol = 10
The desired product (2.16 g) was obtained using 0: 1.
[0067]1H-NMR (CDCl3, Δ): 1.6.
-2.0 (4H, m), 3.69 (5H, m), 4.2
0 (1H, m), 5.06 (2H, s), 5.70 (1
H, m), 7.29 (5H, m), 7.66 (2H,
m), 7.81 (2H, m)
[0068]
[Reference Example 9]Synthesis of N-phthaloyl-ornithine methyl ester
Reference Example 8 Of the compound of formula (2.16 g)
10% palladium-carbon in ethanol solution (100 ml)
(500 mg) at room temperature in a hydrogen atmosphere at room temperature.
Stirred for hours. Filter palladium-carbon using Celite
The solvent was distilled off under reduced pressure. The resulting residue is
It is subjected to Kagel chromatography, and
The desired product (22) was obtained using chloroform: methanol = 100: 3.
3 mg).
[0070]1H-NMR (CDCl3, Δ): 1.7.
−2.1 (4H, m), 3.75 (2H, m), 3.8
3 (3H, s), 7.76 (2H, m), 7.84 (2
H, m)
[0071]
[Reference Example 10]
N- (1-carbobenzoxyindoline-5-carboni
L) phthaloyl-olSynthesis of Nitin Methyl Ester
1-carbobenzoxyindoline-5-ca
Thionyl chloride in ruboxylic acid (297 mg)
(2.5 ml) to give a suspension, and this suspension
And add a catalytic amount of dimethylformamide to it at room temperature for 2 hours.
While stirring. Next, the reaction solution was concentrated to dryness under reduced pressure. Get
The solid thus obtained was dissolved in dichloromethane (7 ml).
Reference Example 9. Compound (250 mg), potassium carbonate
(640 mg) and water (7 ml).
Stirred vigorously at room temperature for 12 hours. Next, the reaction solution is
Extract with chloroform and further add 1N chloroform layer
-Washed with hydrochloric acid solution and dried over sodium sulfate. solvent
Was distilled off under reduced pressure. The residue obtained is purified by silica gel chromatography.
After the chromatography, chloroform:
The desired product (330 mg) was prepared using methanol = 100: 3.
Obtained.
[0073]1H-NMR (CDCl3, Δ): 1.6.
−2.1 (4H, m), 3.12 (2H, t, J = 8.
8Hz), 3.72 (2H, m), 3.76 (3H,
s), 4.08 (2H, t, J = 8.8 Hz), 4.8
4 (1H, m), 5.27 (2H, s), 6.80 (1
H, d, J = 7.8 Hz), 7.1-7.5 (6H,
m), 7.5-7.9 (6H, m)
[0074]
[Reference Example 11]N- (indoline-5-carbonyl) -N-phthaloyl
-Synthesis of ornithine methyl ester
Phenol (300 mg) in 30% bromide water
Reference Example 10 in a hydrogen-acetic acid (8 ml) solution. Compound (33)
0 mg) and stirred at room temperature for 4 hours. Next, the reaction solution
When a large amount of ether was added, a reddish-brown oily substance precipitated.
I did it. Remove the oily substance from chloropho
Suspended in saturated sodium bicarbonate.
Washed with the solution and extracted with chloroform. Chloroform
Dry the layer with sodium sulfate and evaporate the solvent under reduced pressure
Then, the desired product (147 mg) was obtained.
[0076]1H-NMR (CDCl3, Δ): 1.6.
−2.1 (4H, m), 3.04 (2H, t, J = 8.
3Hz), 3.62 (2H, t, J = 8.3Hz),
3.72 (2H, m), 3.75 (3H, s), 4.8
6 (1H, m), 6.5-6.7 (2H, m), 7.5
2 (2H, m), 7.68 (2H, m), 7.82 (2
H, m)
[0077]
Embodiment 7N- [1- [2,4-diamino-6-pteridinyl) me
Tyl] -indoline-5-carbonyl] -N-phthaloy
Synthesis of ru-ornithine methyl ester
Reference Example 11 Compound (146 mg) and 6
-Bromomethyl-2,4-diaminopteridine hydrogen bromide
Isopropanolate adduct (115 mg) in dimethyl
Suspended in acetamide (1.0 ml) at 50-55 ° C
Stir for 4 hours. After cooling, triethylamine
(30 mg) in water (4 ml), stir and then cool.
Extracted with loroform. Chloroform layer with sodium sulfate
After drying with a solvent, the solvent was distilled off under reduced pressure.
The gel is subjected to Ricagel chromatography and used as an elution solvent.
Using a mixed solvent of loroform: methanol = 10: 1
Was obtained (140 mg).
[0079]1H-NMR (CDCl3, Δ): 1.7.
-2.2 (4H, m), 3.06 (2H, t, J = 8.
3Hz), 3.56 (2H, t, J = 8.3Hz),
3.72 (2H, m), 3.76 (3H, s), 4.5
3 (2H, s), 4.88 (1H, m), 6.45-
6.62 (2H, m), 7.56 (2H, m), 7.7
1 (2H, m), 7.84 (2H, m), 8.82 (1
H, s)
[0080]
Embodiment 8N- [1-[(2,4-diamino-6-pteridinyl)
Methyl] -indoline-5-carbonyl] -N-hemif
Synthesis of Talloylu Ornithine (Compound 2)
Embodiment 7 FIG. Compound (140 mg) in 2N
Suspended in sodium hydroxide solution (10 ml), 30
Stirred at C for 12 hours. Dry the reaction mixture under reduced pressure
The yellow solid obtained was dissolved in water (5 ml) and 1N
-Adjust to pH = 3.7 with hydrochloric acid and release for 2 hours in refrigerator
Placed. The deposited precipitate was collected by filtration. The obtained yellow solid
The product is subjected to silica gel chromatography,
And chloroform: methanol: 28% -ammonia water
= 5: 4: 1 using a mixed solvent to give the desired product (20 mg)
Was.
[0082]1H-NMR (DMSO-d6, Δ):
1.5-2.1 (4H, m), 3.14 (2H, t, J
= 8.3 Hz), 3.58 (2H, t, J = 8.3H)
z), 4.38 (1H, m), 4.54 (2H, s),
6.71 (1H, m), 7.3-7.6 (4H, m),
7.6-7.8 (3H, m), 8.08 (1H, m),
8.71 (1H, s)
mp; 195-199 ° C (dec.)
[0083]
[Reference Example 12]N- (3-methoxycarbonylbenzoyl) -N-cal
Synthesis of bobenzoxy-ornithine methyl ester
N-carbobenzoxy-L-ornithine
(2.4 g) in dichloromethane (40 ml)
Phthalic acid monomethyl ester chloride (2.1 g)
Then water (40 ml), potassium carbonate (2.4
g) was added and the mixture was stirred at room temperature for 15 hours. Reduce the pressure of the reaction solution
To 30 ml and adjust to pH = 3 with 1N-hydrochloric acid.
The resulting precipitate was collected by filtration and dried under vacuum. White solid obtained
Is dissolved in low-moisture methanol (100 ml), and this solution is dissolved.
Was cooled to −30 ° C. and stirred for 10 minutes. Next, at the same temperature
Then, thionyl chloride (3 ml) was slowly added dropwise. reaction
The solution was slowly brought to room temperature and refluxed for another 2 hours.
Was. The solvent is distilled off under reduced pressure, and the obtained residue is silica gel.
Chromatography and chloroform as elution solvent
Using methanol: methanol = 100: 1 (600 m
g) was obtained.
[0085]1H-NMR (CDCl3, Δ): 1.
6-2.0 (4H, m), 3.46 (2H, m), 3.
70 (3H, s), 3.89 (3H, s), 4.34
(1H, m), 5.08 (2H, s), 5.88 (1
H, d, J = 7.8 Hz), 7.31 (5H, s),
7.45 (1H, m), 8.05 (2H, m), 8.4
1 (1H, s)
[0086]
[Reference Example 13]N- (3-methoxycarbonylbenzoyl) -ornichi
Synthesis of methyl ester
Reference Example 12 Of the compound (600 mg)
10% palladium-charcoal in a ethanol solution (100 ml)
After adding hydrogen (100 mg), the mixture was added at room temperature under a hydrogen atmosphere at room temperature.
Stirred for 0 hours. Palladium-carbon using celite
After filtration, the solvent was distilled off under reduced pressure. The resulting residue is
The gel is subjected to Ricagel chromatography and used as an elution solvent.
Using roroform: methanol = 100: 3, the desired product (3
60 mg).
[0088]1H-NMR (CDCl3, Δ): 1.6.
-2.0 (4H, m), 3.50 (3H, m), 3.7
2 (3H, s), 3.92 (3H, s), 7.49 (1
H, t, J = 7.8 Hz), 7.63 (1H, m),
8.0-8.2 (2H, m), 8.43 (1H, s)
[0089]
[Reference Example 14]N- (1-carbobenzoxyindoline-5-carboni
) -N- (3-methoxycarbonylbenzoyl) -o
Synthesis of lunitine methyl ester
1-carbobenzoxyindoline-5-ca
Thionyl chloride in ruboxylic acid (350mg)
(5 ml) to make a suspension, and then touch this suspension.
A medium amount of dimethylformamide was added and stirred at room temperature for 2 hours.
Stirred. Next, the reaction solution was concentrated to dryness under reduced pressure. Got
The solid was dissolved in dichloromethane (7 ml) and the solution dissolved.
Reference Example 13. Compound (360 mg), potassium carbonate
(650 mg) and water (7 ml)
Stirred vigorously at warm for 12 hours. Next, pour the reaction solution into water
The mixture was extracted with chloroform.
Washed with hydrochloric acid solution and dried over sodium sulfate. Solvent
The solvent was distilled off under reduced pressure. The residue obtained is chromatographed on silica gel.
After performing chromatography, chloroform:
The desired product (390 mg) was obtained using tanol = 100: 3.
Was.
[0091]1H-NMR (CDCl3, Δ): 1.6.
−2.1 (4H, m), 3.08 (2H, t, J = 8.
3Hz), 3.52 (2H, m), 3.75 (3H,
s), 3.88 (3H, s), 4.06 (2H, t, J
= 8.3 Hz), 4.78 (1H, m), 5.26 (2
H, bs), 7.16 (1H, d, J = 7.3 Hz),
7.2-7.6 (7H, m), 7.65 (2H, m),
7.9-8.1 (2H, m), 8.43 (1H, s)
[0092]
[Reference Example 15]N- (indoline-5-carbonyl) -N- (3-meth
(Xycarbonylbenzoyl) -ornithine methyl ester
Synthesis
30% hydrogen bromide of anisole (0.5 g)
Reference Example 14 in acetic acid (6 ml) solution. Compound (390m
g) was added and stirred at room temperature for 4 hours. Next, add
A reddish-brown oil precipitated upon addition of an amount of ether.
Was. Remove the oily substance from chloroform by removing most of the ether layer.
Suspended in saturated sodium bicarbonate solution
And extracted with chloroform. Chloroform layer
After drying over sodium sulfate, the solvent was distilled off under reduced pressure.
The obtained white solid was subjected to n-hexane-chloroform-meta
Recrystallization from knol gave the desired product (192 mg).
[0094]1H-NMR (CDCl3, Δ): 1.7.
−2.1 (4H, m), 3.05 (2H, t, J = 8.
3Hz), 3.53 (2H, m), 3.67 (2H,
t, J = 8.3 Hz), 3.75 (3H, s), 3.8
9 (3H, s), 4.75 (1H, m), 6.73 (1
H, d, J = 7.8 Hz), 7.16 (1H, d, J =
7.8 Hz), 7.47 (1H, m), 7.55 (2
H, m), 8.09 (2H, m), 8.45 (1H,
s)
[0095]
Embodiment 9N- [1-[(2,4-diamino-6-pteridinyl)
Methyl] -indoline-5-carbonyl] -N- (3-
Methoxycarbonylbenzoyl) -ornithine methyl
Steal Synthesis
Reference Example 15 Compound (192 mg) and 6
-Bromomethyl-2,4-diaminopteridine hydrogen bromide
Acid salt (142 mg) was added to dimethylacetamide (2.5 m
l) and stirred at 50-55 ° C for 4 hours. cooling
Then, water containing triethylamine (43 mg) of the reaction solution
(5 ml), stirred and then extracted with chloroform.
Was. After drying the chloroform layer with sodium sulfate,
The solvent was distilled off under reduced pressure, and the resulting residue was purified by silica gel chromatography.
After performing chromatography, chloroform:
The target compound (110 m
g) was obtained.
[0097]1H-NMR (CDCl3, Δ): 1.7.
−2.1 (4H, m), 3.06 (2H, t, J = 8.
3Hz), 3.55 (4H, m), 3.78 (3H,
s), 3.93 (3H, s), 4.52 (2H, s),
4.79 (1H, m), 6.51 (1H, d, J = 7.
8 Hz), 7.05 (1H, d, J = 7.8 Hz),
7.4-7.7 (3H, m), 8.0-8.2 (2H,
m), 8.45 (1H, m), 8.77 (1H, s)
[0098]
Embodiment 10N- [1-[(2,4-diamino-6-pteridinyl)
Methyl] -indoline-5-carbonyl] -N-isofu
Synthesis of Taroyl-Ornithine
Embodiment 9 FIG. Compound (110 mg)
Dissolved in ethanol (14 ml), and further added with 1N sodium hydroxide.
Lithium solution (0.48 ml) was added and the mixture was heated at 35 ° C for 4.5 hours
While stirring. After stirring at 25 ° C. for 20 hours, water was added to the reaction solution.
(1 ml) was added, and the reaction solution was dried under reduced pressure.
At this time, the external temperature did not exceed 30 ° C. Got
Dissolve the yellow solid in water (5 ml) and add 1N hydrochloric acid to pH
= 3.7 and left in the refrigerator for 2 hours. Precipitation
The resulting precipitate was collected by filtration to obtain the desired product (78 mg).
[0100]1H-NMR (DMSO-d6, Δ):
1.5-2.0 (4H, m), 3.00 (2H, t, J
= 8.8 Hz), 3.32 (2H, m), 3.59 (2
H, t, J = 8.8 Hz), 4.40 (1H, m),
4.56 (2H, s), 6.69 (1H, d, J = 8.
3Hz), 7.56 (1H, m), 7.63 (2H,
m), 8.0-8.2 (2H, m), 8.44 (1H,
s), 8.65 (1H, m), 8.73 (1H, s)
[0101]
[Reference Example 16]N- (4-methoxycarbonylbenzoyl) -N-cal
Synthesis of bobenzoxy-ornithine methyl ester
N-carbobenzoxy-L-ornithine
(2.0 g) in dichloromethane (60 ml) solution
Phthalic acid monomethyl ester chloride (3.0 g)
Then water (60 ml), potassium carbonate (4.8)
g) was added and the mixture was stirred at room temperature for 15 hours. Reduce the pressure of the reaction solution
And concentrated to 50 ml, adjusted to pH = 3 with 1N hydrochloric acid and precipitated.
The resulting precipitate was collected by filtration and dried in vacuo. The obtained white solid
Dissolve in low-moisture methanol (100 ml) and add this solution
It cooled to -30 degreeC and stirred for 10 minutes. Next, at the same temperature
Thionyl chloride (3 ml) was slowly added dropwise. Reaction
The solution was slowly returned to room temperature and refluxed for another 2 hours.
Was. The solvent is distilled off under reduced pressure, and the obtained residue is silica gel.
Chromatography and chloroform as elution solvent
Using methanol: methanol = 100: 1 (710 m
g) was obtained.
[0103]1H-NMR (CDCl3, Δ): 1.6.
−2.1 (4H, m), 3.51 (2H, m), 3.7
4 (3H, s), 3.94 (3H, s), 4.43 (1
H, m), 5.11 (2H, s), 5.53 (1H,
m), 6.63 (1H, bs), 7.34 (5H,
s), 7.83 (2H, d, J = 8.8 Hz), 8.0
8 (2H, d, J = 8.8 Hz)
[0104]
[Reference Example 17]N- (4-methoxycarbonylbenzoyl) -ornichi
Synthesis of methyl ester
Reference Example 16 Of the compound (710 mg)
10% palladium on carbon in ethanol solution (100 ml)
(100 mg), and then added at room temperature under hydrogen atmosphere.
Stirred for hours. Filtration of palladium-carbon using Celite
The solvent was distilled off under reduced pressure. The resulting residue is
It is subjected to Kagel chromatography, and
The desired product (41) was obtained using chloroform: methanol = 100: 3.
0 mg).
[0106]1H-NMR (CDCl3, Δ): 1.6.
−2.1 (4H, m), 3.49 (3H, m), 3.7
3 (3H, s), 3.94 (3H, s), 7.20 (1
H, m), 7.84 (2H, d, J = 8.3 Hz),
8.09 (2H, d, J = 8.3 Hz)
[0107]
[Reference Example 18]N- (1-carbobenzoxyindoline-5-carboni
Ru) -N- (4-methoxycarbonylbenzoyl) -o
Synthesis of lunitine methyl ester
1-carbobenzoxyindoline-5-ca
Thionyl chloride in ruboxylic acid (260mg)
(2.5 ml) to give a suspension, and this suspension
And add a catalytic amount of dimethylformamide to it at room temperature for 2 hours.
While stirring. Next, the reaction solution was concentrated to dryness under reduced pressure. Get
The solid thus obtained was dissolved in dichloromethane (6 ml).
Reference Example 17. Compound (245 mg), potassium carbonate
(812 mg) and water (6 ml).
The mixture was stirred vigorously at room temperature for 12 hours. Next, add the reaction solution to water
Open and extract with chloroform.
Washed with N-hydrochloric acid solution and dried over sodium sulfate. Dissolution
The medium was distilled off under reduced pressure. The resulting residue is
Chromatography and chloroform
The target substance (310 mg) using methanol: methanol 100: 3
I got
[0109]1H-NMR (CDCl3, Δ): 1.7.
-2.2 (4H, m), 3.16 (2H, t, J = 8.
3Hz), 3.61 (1H, m), 3.79 (3H,
s), 3.94 (3H, s), 4.11 (2H, t, J
= 8.3 Hz), 4.83 (1H, m), 5.29 (2
H, s), 6.89 (1H, d, J = 7.3 Hz),
7.02 (1H, m), 7.40 (5H, m), 7.6
6 (2H, d, J = 7.3 Hz), 7.90 (2H,
d, J = 8.8 Hz), 8.08 (2H, d, J = 8.
8Hz)
[0110]
[Reference Example 19]N- (indoline-5-carbonyl) -N- (4-meth
(Xycarbonylbenzoyl) -ornithine methyl ester
Synthesis
30% hydrogen bromide of phenol (1.0 g)
-Reference Example 18 in acetic acid (10 ml) solution. Compound (40)
0 mg) and stirred at room temperature for 4 hours. Next, the reaction solution
When a large amount of ether was added, a reddish-brown oily substance precipitated.
I did it. Remove the oily substance from chloropho
Suspended in saturated sodium bicarbonate.
After washing with the solution, the desired product was extracted with chloroform. Black
The roform layer is dried over sodium sulfate, and the solvent is evaporated under reduced pressure.
Was distilled off. The obtained white solid was washed with n-hexane-chloroform.
Recrystallized from form-methanol to give the desired product (145 mg)
I got
[0112]1H-NMR (CDCl3, Δ): 1.6.
−2.1 (4H, m), 3.05 (2H, t, J = 8.
3Hz), 3.48 (2H, m), 3.62 (2H,
t, J = 8.3 Hz), 3.76 (3H, s), 3.9
4 (3H, s), 4.75 (1H, m), 6.57 (1
H, d, J = 7.8 Hz), 7.19 (1H, d, J =
7.8 Hz), 7.55 (2H, m), 7.89 (2
H, d, J = 8.3 Hz), 8.07 (2H, d, J =
8.3Hz)
[0113]
Embodiment 11N- [1-[(2,4-diamino-6-pteridinyl)
Methyl] indoline-5-carbonyl] -N- (4-meth
Toxylcarbonylbenzoyl) -ornithine methyles
Tell synthesis
Reference Example 19 Compound (140 mg) and 6
-Bromomethyl-2,4-diaminopteridine hydrogen bromide
Acid salt (105 mg) was added to dimethylacetamide (2.0 m
l) and stirred at 50-55 ° C for 4 hours. cooling
Then, water containing triethylamine (32 mg) of the reaction solution
(4 ml), and the mixture is stirred.
Extracted. After drying the chloroform layer with sodium sulfate,
The solvent was distilled off under reduced pressure, and the resulting residue was
After the chromatography, chloroform:
Using a mixed solvent of methanol = 10: 1, the target compound (180
mg).
[0115]1H-NMR (CDCl3, Δ): 1.6.
−2.1 (4H, m), 3.08 (2H, t, 8.8H
z), 3.4-3.7 (4H, m), 3.79 (3H,
s), 3.94 (3H, s), 4.54 (2H, s),
4.83 (1H, m), 6.52 (1H, d, J = 8.
3 Hz), 6.79 (1H, d, J = 6.8 Hz),
7.17 (1H, m), 7.59 (2H, m), 7.9
2 (2H, d, J = 8.3 Hz), 8.09 (2H,
d, J = 8.3 Hz), 8.81 (1H, s)
[0116]
Embodiment 12
N- [1-[(2,4-diamino-6-pteridinyl)
Methyl] indoline-5-carbonyl] -N-terephthalate
Synthesis of Loyl-Ornithine
Embodiment 11 FIG. Compound (150 mg)
Dissolve in ethanol (24 ml) and add 1N
Add thorium solution (0.8ml) and at 35 ° C for 4.5 hours
While stirring. After stirring at 25 ° C. for 20 hours, water was added to the reaction solution.
(1 ml) was added, and the reaction solution was dried under reduced pressure.
At this time, the external temperature did not exceed 30 ° C. Got
Dissolve the yellow solid in water (5 ml) and add 1N hydrochloric acid to pH
= 3.7 and left in the refrigerator for 2 hours. Precipitation
The resulting precipitate was collected by filtration to obtain the desired product (109 mg).
[0118]1H-NMR (CDCl3, Δ): 1.5
−2.0 (4H, m), 3.00 (2H, t, J = 8.
8Hz), 3.30 (2H, m), 3.58 (2H,
t, J = 8.8 Hz), 4.36 (1H, m), 4.5
4 (2H, s), 6.68 (1H, d, J = 8.8H)
z), 7.62 (2H, m), 7.91 (2H, d, J
= 8.3 Hz), 7.99 (2H, d, J = 8.3H)
z), 8.10 (1H, d, J = 7.8 Hz), 8.6
1 (1H, m), 8.71 (1H, s)
mp; 215-220 ° C (dec.)
[0119]
[Reference Example 20]Nt-butoxycarbonyl-γ-anilide-L-glu
Synthesis of α-benzyl tamate
Nt-butoxycarbonyl-L-gluta
Α-Benzyl ester (2.2 g) and triethyl
Amine (0.92 ml) in tetrahydrofuran (8
ml) at -20 ° C under nitrogen atmosphere.
Chill (0.8 ml) in tetrahydrofuran (2 m
l) was added and stirred for 30 minutes. Then, aniline (0.5
ml) and stirred for 1 hour. Gradually return to room temperature
And stirred for a further 20 hours. The solvent was distilled off under reduced pressure to obtain
The obtained residue was dissolved in chloroform. Chloroform layer
Was washed with a saturated aqueous solution of sodium bicarbonate,
And dried under reduced pressure. The resulting residue
Silica gel chromatography, elution solvent
Using chloroform: methanol = 99: 1
(1.7 g) was obtained.
[0121]1H-NMR (CDCl3, Δ): 1.4.
4 (9H, s), 1.79-1.97 (1H, m),
2.27-1.40 (2H, m), 4.32-4.44
(1H, m), 5.16 (2H, s), 5.22-5.
38 (1H, m), 7.08 (1H, t, J = 7.3H
z), 7.26-7.33 (7H, m), 7.55 (2
H, d, J = 7.8 Hz), 8.42 (1H, s)
[0122]
[Reference Example 21]γ-anilide-L-glutamic acid α-benzyl ester
Synthesis of
Reference Example 20 The compound (1.7 g) was cooled with ice
Dissolve in trifluoroacetic acid (8 ml) below and stir for 30 minutes
Was. The solvent is distilled off under reduced pressure, and the residue is dissolved in chloroform.
did. Chloroform layer is saturated aqueous sodium hydrogen carbonate
And then dried over sodium sulfate. Dissolve under reduced pressure
The solvent was distilled off to obtain the desired product (1.3 g).
[0124]1H-NMR (CDCl3, Δ): 1.8
6-2.00 (1H, m), 2.17-2.38 (1
H, m), 2.42-2.53 (2H, m), 3.53
-3.60 (1H, m), 5.15 (2H, s), 7.
07 (1H, t, J = 7.3 Hz), 7.29-7.3
5 (7H, m), 7.48 (2H, d, J = 7.8H
z), 8.27 (1H, bs)
[0125]
[Reference Example 22]N- (1-carbobenzoxyindoline-5-carboni
L) -γ-anilide-L-glutamic acid α-benzyl ester
Steal Synthesis
1-carbobenzoxyindoline-5-ca
Thionyl chloride (2 ml) was added to rubonic acid (419 mg).
The mixture was stirred at room temperature for 2 hours. Next, the reaction solution is concentrated under reduced pressure.
To dryness. The obtained solid is dissolved in dichloromethane (2 ml).
And dissolved in this solution. Of the compound (400
mg) and triethylamine (0.21 ml)
A water solution (2 ml) is added under ice-cooling and nitrogen atmosphere, and stirred overnight.
Stirred. The reaction solution is 1N hydrochloric acid, saturated sodium hydrogen carbonate
Washed sequentially with an aqueous solution and water, and dried over sodium sulfate
Thereafter, the solvent was distilled off under reduced pressure. The residue obtained is silica gel
Chromatography, and elution solvent
Using methane and then chloroform, the desired product (317 m
g) was obtained.
[0127]1H-NMR (CDCl3, Δ): 2.1
0-2.20 (1H, m), 2.29-2.51 (3
H, m), 3.05 (2H, t, J = 8.8 Hz),
4.06 (2H, t, J = 8.8 Hz), 4.76 −
4.88 (1H, m), 5.18 (2H, s), 5.2
8 (2H, bs), 7.05 (1H, t, J = 7.3H)
z), 7.18 (1H, d, J = 7.8 Hz), 7.2
3-7.30 (2H, m), 7.33 (5H, s),
7.39 (5H, s), 7.43-7.66 (4H,
m), 7.80-7.84 (1H, m), 8.57 (1
H, bs)
[0128]
[Reference Example 23]N- (1-carbobenzoxyindoline-5-carboni
B) Synthesis of -γ-anilide-L-glutamic acid
Reference Example 22 Compound (580 mg)
A mixed solvent of roloform: methanol = 1: 2 (30 m
l) and dissolved in a 1N aqueous sodium hydroxide solution (0.9
8 ml) and stirred at room temperature overnight. Water bath temperature 3
The solvent was distilled off under reduced pressure while maintaining the temperature at 0 ° C or lower. Obtained
Was dissolved in water and acidified with 1N hydrochloric acid.
Extracted with chloroform. Sulfuric acid in chloroform layer
After drying with sodium, the solvent was distilled off under reduced pressure to obtain the target compound.
(413 mg) was obtained.
[0130]1H-NMR (CDCl3, Δ): 2.1
7-2.29 (2H, m), 2.52-2.56 (2
H, m), 2.79 (2H, t, J = 7.8 Hz),
3.81 (2H, t, J = 7.8 Hz), 4.51-
4.61 (1H, m), 5.17 (2H, s), 6.9
4 (1H, t, J = 7.3 Hz), 7.13 (2H,
t, J = 7.8 Hz), 7.34 (5H, s), 7.4
3-7.65 (5H, m), 8.03 (1H, bs),
9.02 (1H, s)
[0131]
[Reference Example 24]N- (1-carbobenzoxyindoline-5-carboni
-)-Γ-anilide-L-glutamic acid α-methyles
Tell synthesis
Reference Example 23 Compound (470 mg) was dried.
Dissolve in dry methanol (20 ml) and add trimethylsilyl
Diazomethane (2 ml) was added and the mixture was stirred for 10 hours. Sa
And trimethylsilyldiazomethane (3 ml).
Stirred for 20 hours. After evaporating the solvent under reduced pressure, the obtained
The residue was subjected to silica gel chromatography and eluted.
Chloroform as a medium, then chloroform: methanol
To obtain the desired product (252 mg).
[0133]1H-NMR (CDCl3, Δ): 2.0
6-2.21 (1H, m), 2.31-2.56 (3
H, m), 3.08 (2H, t, J = 8.8 Hz),
3.77 (3H, s), 4.08 (2H, t, J = 8.
8 Hz), 4.77-4.87 (1H, m), 5.28
(2H, s), 7.07 (1H, t, J = 7.3H
z), 7.15 (1H, d, J = 7.8 Hz), 7.2
8 (2H, t, J = 7.8 Hz), 7.37-7.43
(5H, m), 7.58 (2H, d, J = 7.8H
z), 7.62-7.68 (2H, m), 7.86 (1
H, bs), 8.67 (1H, bs)
[0134]
[Reference Example 25]N- (indoline-5-carbonyl) -γ-anilide-
Synthesis of L-glutamic acid α-methyl ester
Reference Example 24. Of the compound (250 mg)
10% palladium on carbon in ethanol solution (10 ml)
(50 mg) at room temperature under a hydrogen atmosphere at 15:00
While stirring. Palladium-carbon is removed by filtration using Celite
Then, the solvent was distilled off under reduced pressure. The residue obtained is silica gel
Chlorophore as the eluting solvent.
Lum: methanol = 99: 1, then chloroform: me
The desired product (172 mg) was obtained using 19: 1 of ethanol.
Was.
[0136]1H-NMR (CDCl3, Δ): 1.9.
9-2.13 (1H, m), 2.36.2.55 (3
H, m), 3.03 (2H, t, J = 8.8 Hz),
3.64 (2H, t, J = 8.8 Hz), 3.77 (3
H, s), 4.08 (1H, bs), 4.79-4.8.
8 (1H, m), 6.55 (1H, d, J = 8.3H
z), 6.92 (1H, d, J = 7.3 Hz), 7.0
8 (1H, t, J = 7.3 Hz), 7.30 (2H,
t, J = 7.8 Hz), 7.53-7.65 (4H,
m), 9.01 (1H, bs)
[0137]
Embodiment 13N- [1-[(2,4-diamino-6-pteridinyl)
Methyl] -indoline-5-carbonyl] -γ-anili
Synthesis of do-L-glutamic acid α-methyl ester
Reference Example 25 Compound (169 mg) and 6
-Bromomethyl-2,4-diaminopteridine hydrogen bromide
Acid salt (223 mg) in dimethylacetamide (5 ml)
And stirred at room temperature for 24 hours. The reaction solution is silica
Gel chromatography was performed, and acetic acid was used as the elution solvent.
Chill, then use chloroform: methanol = 19: 1
Thus, the desired product (82 mg) was obtained.
[0139]1H-NMR (CDCl3, Δ): 2.0
1-2.09 (1H, m), 2.39-2.48 (3
H, m), 3.04 (2H, t, J = 8.8 Hz),
3.58 (2H, t, J = 8.8 Hz), 3.78 (3
H, s), 4.53 (2H, s), 4.79-4.89.
(1H, m), 6.48 (1H, d, J = 7.8H
z), 6.87 (1H, d, J = 7.8 Hz), 7.0
8 (1H, t, J = 7.8 Hz), 7.26-7.32
(2H, m), 7.59-7.64 (4H, m), 8.
81 (1H, s)
[0140]
Embodiment 14N- [1-[(2,4-diamino-6-pteridinyl)
Methyl] -indoline-5-carbonyl] -γ-anili
Synthesis of do-L-glutamic acid
Embodiment 13 FIG. Compound (82 mg)
Dissolved in a mixed solvent (15 ml) of knol: water = 2: 1,
A 1N aqueous solution of sodium hydroxide (0.15 ml) was added.
Then, the mixture was stirred at room temperature for 60 hours. Water bath temperature below 30 ℃
The solvent was distilled off under reduced pressure while maintaining the pressure. The resulting residue
Dissolve in saturated aqueous sodium bicarbonate and add 1N hydrochloric acid
And adjusted to pH = 3.7. The deposited orange precipitate
Filtration yielded the desired product (61 mg).
[0142]1H-NMR (DMSO-d6, Δ):
1.99-2.23 (2H, m), 2.42-2.51
(2H, m), 2.98 (2H, t, J = 7.8H
z), 3.59 (2H, t, J = 8.3 Hz), 4.3
2-4.43 (1H, m), 4.56 (2H, s),
6.70 (1H, d, J = 7.8 Hz), 6.90 (2
H, bs), 7.00 (1H, t, J = 7.8 Hz),
7.26 (2H, t, J = 7.8 Hz), 7.55-
7.66 (4H, m), 7.72-7.85 (1H,
m), 7.89-7.97 (1H, m), 8.20 (1
H, d, J = 7.3 Hz), 8.75 (1H, s),
9.93 (1H, s)
[0143]
[Reference Example 26]Nt-butoxycarbonyl-γ- (2-methoxycal
Bonylanilide) -L-glutamic acid α-benzyles
Tell synthesis
Nt-butoxycarbonyl-L-gluta
Tetrahydric acid α-benzyl ester (496 mg)
In a drofuran solution (5 ml), ice-cooled, under a nitrogen atmosphere,
N, N'-carbonyldiimidazole (262 mg)
The mixture was stirred for 1 hour. Next, methyl o-aminobenzoate
(0.19 ml) in tetrahydrofuran (2 m
After l) was added, the mixture was stirred for 5 hours. Gradually return to room temperature,
The mixture was further stirred for 48 hours. The solvent was distilled off under reduced pressure to obtain
The residue was subjected to silica gel chromatography and eluted.
Using chloroform as a solvent, the desired product (273 mg)
I got
[0145]1H-NMR (CDCl3, Δ): 1.4.
1 (9H, s), 2.04-2.18 (1H, m),
2.20-2.32 (1H, m), 2.48-2.57
(2H, m), 3.92 (3H, s), 4.34-4.
47 (1H, m), 5.18 (2H, s), 5.19-
5.27 (1H, m), 7.08 (1H, t, J = 7.
8Hz), 7.34 (5H, s), 7.53 (1H,
t, J = 7.3 Hz), 8.02 (1H, d, J = 7.
8 Hz), 8.68 (1H, d, J = 7.8 Hz), 1
1.06 (1H, s)
[0146]
[Reference Example 27]γ- (2-methoxycarbonylanilide) -L-gluta
Synthesis of α-benzyl ester of formic acid
Reference Example 26 Compound (632 mg) on ice
Dissolve in trifluoroacetic acid (4.5 ml) under cooling for 90 minutes
Stirred. The solvent was distilled off under reduced pressure.
Was dissolved. Chloroform layer is saturated sodium bicarbonate
After washing with an aqueous solution and drying over sodium sulfate,
The solvent was distilled off with. The obtained residue is subjected to silica gel chromatography.
Chromatography, chloroform as elution solvent, then
Using chloroform: methanol = 97: 3
(486 mg).
[0148]1H-NMR (CDCl3, Δ): 1.9.
1-2.02 (1H, m), 2.20-2.30 (1
H, m), 2.55-2.64 (2H, m), 3.56
-3.62 (1H, m), 3.92 (3H, s), 5.
17 (2H, s), 7.07 (1H, t, J = 8.3H)
z), 7.35 (5H, s), 7.53 (1H, t, J
= 8.8 Hz), 8.02 (1H, d, J = 8.3H)
z), 8.69 (1H, d, J = 8.8 Hz), 11.
08 (1H, bs)
[0149]
[Reference Example 28]1-[(2,4-diamino-6-pteridinyl) methyl
[Indone-5-carboxylic acid]
1-carbobenzoxyindoline-5-ca
Rubonic acid (87 mg) and 6-bromomethyl-2,4-di
Aminopteridine hydrobromide 1/2 isopropanol
The adduct (136 mg) was converted to dimethylacetamide (2 m
1) and stirred at 55 ° C. for 4 hours. Water in the reaction solution
(20 ml) and left in the refrigerator overnight. Deposited
The solid is collected by filtration and added to a small amount of 1N aqueous sodium hydroxide solution.
It was dissolved and adjusted to pH = 6.5 using 1N-hydrochloric acid.
The precipitated brown precipitate was collected by filtration to obtain the desired product (56 mg).
Was.
[0151]1H-NMR (DMSO-d6, Δ):
3.01 (2H, t, J = 8.8 Hz), 3.64 (1
H, t, J = 8.8 Hz), 4.60 (2H, s),
6.68 (1H, d, J = 8.3 Hz), 7.16 (2
H, bs), 7.58 (1H, s), 7.65 (1H,
7. d, J = 8.3 Hz), 8.09 (1H, bs),
25 (1H, bs), 8.77 (1H, s)
[0152]
Embodiment 15N- [1-[(2,4-diamino-6-pteridinyl)
Methyl] -indoline-5-carbonyl] -γ- (2-
Methoxycarbonylanilide) -L-glutamic acid α-
Synthesis of methyl ester
Reference Example 28 Compound (134 mg) and 1
Of hydroxybenzotriazole (108 mg)
Ice-cooled, nitrogen atmosphere in chilled formamide suspension (5 ml)
Infrared, dicyclohexylcarbodiimide (123 mg)
Dimethylformamide solution (1.5 ml)
Minutes. Next, Reference Example 27. The compound dimethyl
After adding formamide solution (1.5 ml), slowly
The mixture was returned to warm temperature and stirred for 24 hours. The reaction solution was chromatographed on silica gel
Ethyl acetate as the elution solvent, then
Using chloroform: methanol = 19: 1
(29 mg) was obtained.
[0154]1H-NMR (CDCl3, Δ): 2.3
2-2.46 (2H, m), 2.46-2.70 (2
H, m), 2.96 (2H, t, J = 8.8 Hz),
3.49 (2H, t, J = 8.3 Hz), 3.89 (3
H, s), 4.46 (2H, s), 4.83-4.90.
(1H, m), 5.20 (2H, s), 6.40 (1
H, d, J = 8.3 Hz), 7.05 (1H, t, J =
8.3 Hz), 7.14 (1H, d, J = 7.8H)
z), 7.34 (5H, s), 7.41-7.59 (3
H, m), 7.96 (1H, d, J = 8.3 Hz),
8.64 (1H, d, J = 8.3 Hz), 8.77 (1
H, s)
[0155]
Embodiment 16N- [1-[(2,4-diamino-6-pteridinyl)
Methyl] -indoline-5-carbonyl] -γ- (2-
Synthesis of (carboxyanilide) -L-glutamic acid
Embodiment 15 FIG. Compound (28 mg)
And 1N sodium hydroxide
Aqueous solution (0.41 ml) and stirred at 10 ° C for 5 hours.
Stirred. While maintaining the temperature of the water bath at 30 ° C or less, under reduced pressure
The solvent was distilled off. The resulting residue is washed with saturated sodium bicarbonate
And pH was adjusted to 3.7 using 1N hydrochloric acid.
It was adjusted. The orange precipitate that precipitated was collected by filtration, and the desired product (21
mg).
[0157]1H-NMR (DMSO-d6, Δ):
1.95-2.25 (2H, m), 2.39-2.58
(2H, m), 2.98 (2H, t, J = 8.3H
z), 3.59 (2H, t, J = 8.3 Hz), 4.3
8-4.50 (1H, m), 4.57 (2H, s),
6.69 (1H, d, J = 8.3 Hz), 7.12 (1
H, t, J = 7.8 Hz), 7.24-7.35 (2
H, m), 7.51-7.64 (3H, m), 7.96.
(1H, d, J = 7.8 Hz) 8.04-8.39 (4
H, m), 8.47 (1H, d, J = 7.8 Hz),
8.78 (1H, s), 11.25 (2H, s)
[0158]
[Reference Example 29]Nt-butoxycarbonyl-L-glutamic acid α-meth
Synthesis of tyl γ-benzyl diester
Nt-butoxycarbonyl-L-gluta
Dimethyl phosphoric acid γ-benzyl ester (5.0 g)
Lumamide (75 ml) solution in sodium bicarbonate
(2.5 g) was suspended in methyl iodide (10.5 g).
2 g) in dimethylformamide (75 ml)
Stirred at room temperature for 24 hours. The reaction was concentrated under reduced pressure
Thereafter, water (70 ml) was added, and ethyl acetate: n-hexane was added.
= 1: 1 solution. The organic layer is washed with water,
After drying with thorium, the solvent was distilled off under reduced pressure. Get
The residue was subjected to silica gel chromatography and eluted.
Using ethyl acetate: n-hexane = 1: 2 as a solvent
The desired product (5.2 g) was obtained.
[0160]1H-NMR (CDCl3, Δ): 1.4.
3 (9H, s), 1.92-2.01 (1H, m),
2.11-2.37 (1H, m), 2.51-2.42
(2H, m), 3.73 (3H, s), 4.23-4.
40 (1H, m), 5.12 (2H, s), 7.35
(5H, s)
[0161]
[Reference Example 30]Nt-butoxycarbonyl-L-glutamic acid α-meth
Synthesis of tyl ester
Reference Example 29 Of the compound (5.2 g) of
10% palladium-carbon in ethanol solution (30 ml)
(1.1 g) and then at room temperature under hydrogen atmosphere for 15:00
While stirring. Palladium-carbon is removed by filtration using Celite
Then, the solvent was distilled off under reduced pressure. The obtained residue is saturated with carbonic acid.
Dissolve in aqueous sodium hydrogen, wash with chloroform
Was. After separating the aqueous layer, pH = 4 using 5% citric acid.
And extracted with chloroform. Chloroform layer
After drying over sodium sulfate, the solvent was distilled off under reduced pressure,
The desired product (3.9 g) was obtained.
[0163]1H-NMR (CDCl3, Δ): 1.4.
4 (9H, s), 1.89-2.04 (1H, m),
2.09-2.27 (1H, m), 3.75 (3H,
s), 4.34 (1H, m), 5.17-5.21 (1
H, m), 9.38 (1H, bs)
[0164]
[Reference Example 31]Nt-butoxycarbonyl-γ- (3-ethoxycal
Bonylanilide) -L-glutamic acid α-methyl ester
Synthesis
Reference Example 30 (1.6 g) and 1-
Dichloro of hydroxybenzotriazole (0.8g)
To a methane suspension (10 ml) was added ice-cooled and nitrogen atmosphere.
Dichloro of cyclohexylcarbodiimide (1.5 g)
A methane solution (5 ml) was added and stirred for 30 minutes. Then
After addition of ethyl m-aminobenzoate (1.5 g),
The mixture was returned to room temperature and stirred for 20 hours. Evaporate the solvent under reduced pressure
Then, ethyl acetate was added to the obtained residue, and white insolubles were removed by filtration.
did. The filtrate is concentrated under reduced pressure, and the resulting residue is
Chlorophore as the eluting solvent.
Lum, then use chloroform: methanol = 99: 1
Thus, the desired product (2.5 g) was obtained.
[0166]1H-NMR (CDCl3, Δ): 1.3.
8 (3H, t, J = 7.1 Hz), 1.47 (9H,
s), 1.82 to 2.04 (1H, m), 2.20-
2.39 (1H, m), 2.45-2.51 (2H,
m), 3.74 (3H, s), 4.32-4.42 (1
H, m), 4.37 (2H, q, J = 7.1 Hz),
5.37 (1H, bd, J = 7.3 Hz), 7.40
(1H, t, J = 7.8 Hz), 7.78 (1H, d,
J = 7.8 Hz), 7.96 (1H, d, J = 9.3H)
z), 8.13 (1H, s), 8.83 (1H, bs)
[0167]
[Reference Example 32]γ- (3-ethoxycarbonylanilide) -L-gluta
Synthesis of α-methyl ester of formic acid
Reference Example 31 Ice-cooled compound (2.5 g)
Dissolve in trifluoroacetic acid (15 ml) under stirring for 1 hour
did. The solvent was distilled off under reduced pressure, and the residue was dissolved in chloroform.
I understand. Chloroform layer is saturated aqueous sodium bicarbonate
After washing with liquid and drying over sodium sulfate, dissolve under reduced pressure.
The medium was distilled off. The obtained residue is subjected to silica gel chromatography.
And then eluted with chloroform: methanol
To obtain the desired product (1.6 g).
[0169]1H-NMR (CDCl3, Δ): 1.3.
9 (3H, t, J = 7.1 Hz), 1.74 (2H,
s), 1.82-1.99 (1H, m), 2.15
2.32 (1H, m), 2.52-2.62 (2H,
m), 3.54-3.60 (1H, m), 3.74 (3
H, s), 4.37 (2H, q, J = 7.1 Hz),
7.39 (1H, t, J = 7.8 Hz), 7.77 (1
H, d, J = 7.3 Hz), 7.94 (1H, d, J =
7.8 Hz), 7.99 (1H, s), 8.63 (1
H, bs)
[0170]
[Reference Example 33]N- (1-carbobenzoxyindoline-5-carboni
) -Γ- (3-ethoxycarbonylanilide) -L-
Synthesis of glutamic acid α-methyl ester
1-carbobenzoxyindoline-5-ca
Thionyl chloride (4 ml) was added to rubonic acid (612 mg).
The mixture was stirred at room temperature for 2 hours. Next, the reaction solution is concentrated under reduced pressure.
To dryness. The solid obtained is diluted with dichloromethane (4 ml)
In Reference Example 32. Compound (52)
9mg) and triethylamine (0.36ml)
Methane solution (4 ml) was added under ice-cooling and nitrogen atmosphere.
Stirred overnight. The reaction solution was diluted with 2N hydrochloric acid and saturated sodium bicarbonate.
Wash sequentially with aqueous solution of water and water, dry over sodium sulfate
After that, the solvent was distilled off under reduced pressure. The obtained residue is silica
Gel chromatography.
Form, then chloroform: methanol = 99: 1
To give the desired product (870 mg).
[0172]1H-NMR (CDCl3, Δ): 1.3.
7 (3H, t, J = 7.1 Hz), 2.22-2.08
(1H, m), 2.36-2.57 (3H, m), 3.
06 (2H, t, J = 8.8 Hz), 3.77 (3H,
s), 4.07 (2H, t, J = 8.8 Hz), 4.3
0-4.40 (2H, q, J = 7.1 Hz), 4.78
-4.87 (1H, m), 5.28 (2H, bs),
7, 13 (1H, d, J = 7.8 Hz), 7, 30−
7.43 (6H, m), 7.60-7.67 (2H,
m), 7.74 (1H, d, J = 7.8 Hz), 7.8
9 (1H, d, J = 7.8 Hz), 8.12 (1H, b
s), 8.96 (1H, bs)
[0173]
[Reference Example 34]N- (indoline-5-carbonyl) -γ- (3-etho
Xycarbonylanilide) -L-glutamic acid α-methyl
Synthesis of ester
Reference Example 33 Of the compound (842 mg)
10% palladium on carbon in ethanol solution (11 ml)
(0.17 g) was added at room temperature under a hydrogen atmosphere at room temperature.
Stirred for hours. Filter palladium-carbon using Celite
The solvent was distilled off under reduced pressure. The obtained residue is silica
Gel chromatography.
Form, then chloroform: methanol = 99: 1
This gave the desired product (448 mg).
[0175]1H-NMR (CDCl3, Δ): 1.3.
6 (3H, t, J = 7.1 Hz), 2.05-2.25
(1H, m), 2.25-2.48 (1H, m), 2.
25-2.48 (2H, m), 2.93 (2H, t, J
= 8.8 Hz), 3.57 (2H, t, J = 8.8H)
z), 3.71 (3H, s), 4.18 (1H, b
s), 4.34 (2H, t, q, J = 7.1 Hz),
4.73-4.84 (1H, m), 6.46 (1H,
d, J = 8.8 Hz), 7.16 (1H, d, J = 7.
8 Hz), 7.32 (1H, t, J = 7.8 Hz),
7.50-7.53 (2H, m), 7.73 (1H,
d, J = 7.8 Hz), 7.87 (1H, d, J = 7.
3 Hz), 8.19 (1H, s), 9.39 (1H, b
s)
[0176]
Embodiment 17N- [1-[(2,4-diamino-6-pteridinyl)
Methyl] -indoline-5-carbonyl] -γ- (3-
Ethoxycarbonylanilide) -L-glutamic acid α-
Synthesis of methyl ester
Reference Example 34. Compound (448 mg) and 6
-Bromomethyl-2,4-diaminopteridine hydrogen bromide
Isopropanolate adduct (587 mg) in dimethyl
Suspend in acetamide (5 ml) and stir at room temperature for 36 hours.
Stirred. The reaction solution was subjected to silica gel chromatography.
And then eluted with ethyl acetate and then chloroform:
The desired product (653 mg) was obtained using methanol = 9: 1.
Was.
[0178]1H-NMR (DMSO-d6, Δ):
1.34 (3H, t, J = 6.8 Hz), 1.96−
2.32 (2H, m), 2.32-2.59 (2H,
m), 3.00 (2H, t, J = 7.3 Hz), 3.5
6-3.66 (5H, s), 4.32 (2H, q, J =
6.5Hz), 4.40-4.56 (3H, m), 6.
66-6.71 (3H, bs), 7.39 (1H, t,
J = 7.8 Hz), 7.63-7.67 (3H, m),
7.84 (1H, d, J = 7.3 Hz), 8.22 (1
H, s), 8.32 (1H, d, J = 7.3 Hz),
8.73 (1H, s), 10.11 (1H, s)
[0179]
Embodiment 18N- [1-[(2,4-diamino-6-pteridinyl)
Methyl] -indoline-5-carbonyl] -γ- (3-
Synthesis of (carboxyanilide) -L-glutamic acid
Embodiment 17 FIG. Compound (303 mg)
Dissolve in ethanol (10 ml) and add 1N sodium hydroxide
Aqueous solution (1.06 ml) and stirred at room temperature for 12 hours
did. Water (1 ml) was added, and the mixture was further stirred for 2 hours. water
The solvent is distilled off under reduced pressure while keeping the temperature of the bath at 30 ° C or less
did. The residue obtained is taken up in a saturated aqueous sodium hydrogen carbonate solution.
It was dissolved and adjusted to pH = 3.7 using 1N-hydrochloric acid.
The precipitated orange precipitate was collected by filtration, and the desired product (157 mg) was obtained.
Obtained.
[0181]1H-NMR (DMSO-d6, Δ):
1.97-2.25 (2H, m), 2.42-2.58
(2H, m), 2.99 (2H, t, J = 8.8H
z), 3.59 (2H, t, J = 8.8 Hz), 4.3
3-4.45 (1H, m), 4.59 (2H, s),
6.71 (1H, d, J = 8.3 Hz), 6.93 (2
H, bs), 7.39 (1H, t, J = 7.8 Hz),
7.57-7.82 (5H, m), 7.88-8.04
(1H, m), 8.06-8.12 (1H, m), 8.
15-8.26 (2H, m), 8.75 (1H, s),
10.12 (1H, s)
[0182]
[Reference Example 35]N-carbobenzoxy-γ-N ′, N′-dimethylami
Synthesis of α-benzyl ester of do-L-glutamic acid
N-carbobenzoxy-L-glutamic acid
α-benzyl ester (508 mg) and triethylamido
(0.19 ml) in tetrahydrofuran (2 m
l) Ethyl chlorocarbonate at -20 ° C under nitrogen atmosphere
(0.14 ml) was added and stirred for 30 minutes. Next,
Tyl hydrochloride (112 mg) and triethylamine (0.1
9 ml) of a dichloromethane solution (3 ml)
Stir for 1 hour. Gradually return to room temperature and stir for an additional 24 hours.
Stirred. The solvent was distilled off under reduced pressure, and the resulting residue was
Dissolved in form. Saturated NaHCO 3 in chloroform layer
Washed with 1N-hydrochloric acid and dried over sodium sulfate
After drying, the solvent was distilled off under reduced pressure. The resulting residue is
The gel is subjected to Ricagel chromatography and used as an elution solvent.
Using roroform: methanol = 49: 1, the desired product (4
53 mg).
[0184]1H-NMR (CDCl3, Δ): 1.9.
7-2.37 (4H, m), 2.86 (3H, s),
2.90 (3H, s), 4.39-4.41 (1H,
m), 5.10 (2H, s), 5.17 (2H, s),
5.86-5.89 (1H, m), 7.34 (10H,
s)
[0185]
[Reference Example 36]N-carbobenzoxy-γ-N ′, N′-dimethylami
Synthesis of do-L-glutamic acid
Reference Example 35 Of the compound (450 mg)
1N-sodium hydroxide aqueous solution in a ethanol solution (5 ml)
The solution (1.15 ml) was added and stirred at room temperature overnight. water
The solvent is distilled off under reduced pressure while maintaining the temperature of the bath at 30 ° C or less.
did. The residue obtained is dissolved in water and acidified with 1N hydrochloric acid.
After that, extraction was performed using chloroform. Chlorophor
After drying the solvent layer with sodium sulfate, the solvent was distilled off under reduced pressure.
This gave the desired product (341 mg).
[0187]1H-NMR (CDCl3, Δ): 1.9.
3-2.06 (1H, m), 2.21-2.33 (1
H, m), 2.42-2.56 (1H, m), 2.76
-2.84 (1H, m), 2.98 (3H, s), 3.
00 (3H, s), 4.19-4.27 (1H, m),
5.09 (2H, s), 6.04-6.06 (1H,
m), 7.37 (10H, s)
[0188]
[Reference Example 37]N-carbobenzoxy-γ-N ′, N′-dimethylami
Synthesis of do-L-glutamic acid α-methyl ester
Reference Example 36. Compound (353 mg) was dried.
Dissolve in dry methanol (4 ml) and add
Azomethane (5 ml) was added and stirred for 2 hours. Under reduced pressure
The solvent was distilled off to obtain the desired product (338 mg).
[0190]1H-NMR (CDCl3, Δ): 1.9.
6-2.43 (4H, m), 2.92- (3H, s),
2.95 (3H, s), 3.74 (3H, s), 4.2
8-4.40 (1H, m), 5.10 (2H, s),
5.80 (1H, m), 7.35 (5H, s)
[0191]
[Reference Example 38]γ-N ′, N′-dimethylamide-L-glutamic acid α
-Synthesis of methyl ester
Reference Example 37 Of compound (580 mg)
10% palladium on carbon in ethanol solution (10 ml)
(70 mg) and then at room temperature under a hydrogen atmosphere at 15:00
While stirring. Palladium-carbon is removed by filtration using Celite
Then, the solvent was distilled off under reduced pressure. The residue obtained is silica gel
Chlorophore as the eluting solvent.
Lum: methanol = 19: 1 using the desired product (160 m
g) was obtained.
[0193]1H-NMR (CDCl3, Δ): 1.7.
4-1.92 (1H, m), 2.06-2.23 (1
H, m), 2.47 (2H, t, J = 7.3 Hz),
2.95 (3H, s), 3.02 (3H, s), 3.4
9-3.56 (1H, m), 3.73 (3H, s)
[0194]
[Reference Example 39]N- (1-carbobenzoxyindoline-5-carboni
) -Γ-N ', N'-dimethylamide-L-glutami
Of α-Methyl Ester
1-carbobenzoxyindoline-5-ca
Thionyl chloride (2 ml) was added to rubonic acid (295 mg).
The mixture was stirred at room temperature for 2 hours. Next, the reaction solution is concentrated and dried under reduced pressure.
Hardened. The solid obtained is taken up in dichloromethane (2 ml)
After dissolving in this solution, Reference Example 38. Of the compound (160
mg) and triethylamine (0.18 ml)
Add methane solution (2.5 ml) under ice-cooling and nitrogen atmosphere
Stirred overnight. The reaction solution was 1N-hydrochloric acid, saturated sodium bicarbonate
Wash sequentially with aqueous solution of lithium and water and dry over sodium sulfate
After that, the solvent was distilled off under reduced pressure. The resulting residue is
It is subjected to Kagel chromatography, and
Chloroform, then chloroform: methanol = 99: 1
Was used to obtain the desired product (359 mg).
[0196]1H-NMR (CDCl3, Δ): 2.2
2-2.32 (2H, m), 2.43-2.55 (2
H, m), 2.94 (3H, s), 2.98 (3H,
s), 3.15 (2H, t, J = 8.8 Hz), 3.7
6 (3H, s), 4.10 (2H, t, J = 8.8H)
z), 4.58-4.68 (1H, m), 5.28 (2
H, s), 7.36-7.41 (6H, m), 7.71.
(1H, s), 7.90 (1H, d, J = 5.9 Hz)
[0197]
[Reference Example 40]N- (indoline-5-carbonyl) -γ-N ', N'
-Dimethylamide-L-glutamic acid α-methyl ester
Synthesis
Reference Example 39 Of the compound (359 mg)
10% palladium-carbon (7 ml) was added to a ethanol solution (5 ml).
0 mg), and then stirred at room temperature for 15 hours under a hydrogen atmosphere.
did. The palladium-carbon was removed by filtration using Celite to reduce
The solvent was distilled off under pressure. The residue obtained is purified by silica gel chromatography.
After the chromatography, chloroform:
The desired product (131 mg) was prepared using methanol = 99: 1.
Obtained.
[0199]1H-NMR (CDCl3, Δ): 2.1
9-2.30 (2H, m), 2.44-2.53 (2
H, m), 2.93 (3H, s), 2.97 (3H,
s), 3.04 (2H, t, J = 8.3 Hz), 3.6.
2 (2H, t, J = 8.3 Hz), 3.75 (3H,
s), 4.14 (1H, bs), 4.60-4.70.
(1H, m), 6.56 (1H, d, J = 7.8H
z), 7.51-7.62 (3H, m)
[0200]
Embodiment 19N- [1-[(2,4-diamino-6-pteridinyl)
Methyl] -indoline-5-carbonyl] -γ-N ′,
N'-dimethylamido-L-glutamic acid α-methyl ester
Steal Synthesis
Reference Example 40 Compound (131 mg) and 6
-Bromomethyl-2,4-diaminopteridine hydrogen bromide
Isopropanolate adduct (233 mg) in dimethyl
Suspend in acetamide (4 ml) and stir at room temperature for 24 hours.
Stirred. The reaction solution was subjected to silica gel chromatography.
And then eluted with ethyl acetate and then chloroform:
The desired product (95 mg) was obtained using methanol = 9: 1.
Was.
[0202]1H-NMR (CDCl3, Δ): 1.9.
8-2.17 (2H, m), 2, 42 (2H, t, J =
6.8 Hz), 2.84 (3H, s), 2.94 (3
H, s), 3.00 (2H, t, J = 8.3 Hz),
3.59 (2H, t, J = 8.3 Hz), 3.64 (3
H, s), 4.30-4.42 (1H, m), 4.55
(2H, s), 6.68 (1H, d, J = 7.3H
z), 7.60-7.64 (2H, m), 8.34 (1
H, d, J = 7.3 Hz), 8.71 (1H, s)
[0203]
Embodiment 20
N- [1-[(2,4-diamino-6-buteridinyl)
Methyl] -indoline-5-carbonyl] -γ-N ',
Synthesis of N'-dimethylamido-L-glutamic acid
Embodiment 19 FIG. Compound (70 mg)
Dissolved in ethanol (5 ml) and 1N aqueous sodium hydroxide
Add the solution (0.15 ml) and stir at room temperature for 12 hours
Was. Water (2 ml) was added, and the mixture was further stirred for 5 hours. Bathing
The solvent was distilled off under reduced pressure while maintaining the temperature at 30 ° C or lower.
Was. The obtained residue is dissolved in a saturated aqueous sodium hydrogen carbonate solution.
Then, the pH was adjusted to 3.7 using 1N-hydrochloric acid. Occasionally
The resulting orange precipitate was collected by filtration to obtain the desired product (16 mg).
Was.
[0205]1H-NMR (DMSO-d6, Δ):
1.96-2.08 (2H, m), 2.41 (2H,
t, J = 7.1 Hz), 2.82 (3H, s), 2.9
2 (3H, s), 3.01 (2H, t, J = 7.8H
z), 3.62 (2H, t, J = 7.8 Hz), 4.2
7-4.37 (1H, m), 4.62 (2H, s),
6.72 (1H, d, J = 8.8 Hz), 7.61-
7.64 (2H, m), 8.24 (1H, d, J = 6.
8Hz), 8.87 (1H, s), 12.46 (1H,
bs)
[0206]
[Reference Example 41]N-1-[(2,4-diamino-6-pteridinyl) me
Tyl] 1,2,3,4-tetrahydro-6-quinoline
Synthesis of carboxylic acid
6-bromomethyl-2,4-diaminopte
Lysine hydrobromide / isopropanol adduct (178
mg) and 1,2,3,4-tetrahydro-6-quinoli
Carboxylic acid (55 mg) was added to dimethylacetamide (3
ml) and stirred at 60-65 ° C overnight. After cooling
Water (10 ml) was added to the reaction mixture, and the reaction mixture was cooled with ice-water.
Is adjusted to pH = 3.5 with 1N-hydrochloric acid and left overnight in a cool place
did. The deposited precipitate was collected by filtration, and the desired product (70 mg) was obtained.
Obtained.
[0208]1H-NMR (DMSO-d6, Δ):
2.08 (2H, t, J = 8 Hz), 2.88 (2H, t, J = 8 Hz)
t, J = 8 Hz), 3.68 (2H, t, J = 8H)
z), 4.72 (2H, s), 6.62 (1H, d, J
= 9 Hz), 7.48 (2H, m), 8.51 (1H,
s)
[0209]
Embodiment 21N-1-[(2,4-diamino-6-pteridinyl) me
Tyl] 1,2,3,4-tetrahydro-6-quinoline
Synthesis of carbonyl] -diethyl L-glutamate
Triethylamine (60 mg) and diethyl
Phosphorocyanidate (98mg) in anhydrous dimethylform
Muamide (6 ml). of
The compound (60 mg) was added and stirred. After dissolution, reaction
Stir the solution at 80 ° C for 3 minutes, then return to room temperature for 10 minutes
Stirred. Then triethylamine (20mg) and glue
Tamamic acid diethyl ester hydrochloride (40 mg) was added,
Stirred at 80 ° C. for 2 hours. After the reaction, the solvent is distilled off under reduced pressure.
Chloroform was added to the residue, and the chloroform layer was saturated.
Washed with aqueous sodium bicarbonate. Chloroform layer with magnesium sulfate
After drying with, the solvent was distilled off under reduced pressure.
Gel column chromatography, elution solvent
Using a mixed solvent of chloroform: methanol = 10: 1
The desired product (50 mg) was obtained.
[0211]1H-NMR (DMSO-d6, Δ):
1.1-1.4 (6H, m), 1.8-2.4 (4H,
m), 2.40 (2H, t, J = 8 Hz), 2.82
(2H, t, J = 8 Hz), 3.51 (2H, t, J =
8 Hz), 4.0-4.3 (4H, m), 4.64 (1
H, m), 4.75 (2H, s), 6.65 (1H,
d, J = 3 Hz), 7.47 (2H, m), 8.65
(2H, s)
[0212]
Embodiment 22
N-1-[(2,4-diamino-6-pteridinyl) me
Chill] 1,2,3,4-Tetrahydro-6-quinoline
Synthesis of carbonyl] -L-glutamic acid
Embodiment 21 FIG. Compound (50 mg)
L in ethanol (10 ml), 1N
An aqueous solution of thorium (0.24 ml) was added, and at the same temperature 4.
Stir for 5 hours. Further, stirring was continued at 25 ° C. for 20 hours.
Thereafter, water (1 ml) was added to the reaction solution. Ice-water cooling, anti
The reaction solution was adjusted to pH = 3.7 with 1N hydrochloric acid and left overnight in a cool place.
I left it. The deposited precipitate was collected by filtration, and the target product (27 m
g) was obtained.
[0214]1H = NMR (DMSO-d6, Δ):
1.8-2.2 (4H, m), 2.31 (2H, t, J
= 8 Hz), 2.75 (2H, t, J = 8 Hz), 3.
60 (2H, t, J = 8 Hz), 4.36 (1H,
m), 4.70 (2H, s), 6.62 (1H, d, J
= 9 Hz), 7.51 (2H, m), 8.62 (1H,
s)
mp; 204-208 ° C (dec.)
[0215]
[Reference Example 42]4-[(2,4-diamino-6-pteridinyl) methyl
Ru] -3,4-dihydro-2H-1,4-benzoxa
Synthesis of methyl gin-7-carboxylate
6-bromomethyl-2,4-diaminopte
Lysine hydrobromide / isopropanol adduct (410
mg) and 3,4-dihydro-2H-1,4-benzooxy
Methyl sagin-7-carboxylate (200 mg)
Suspended in lucetamide (10 ml), bath temperature 65 ° C 4
And stirred at 90 ° C. for 19 hours. After cooling,
Cetamide is concentrated under reduced pressure, and chloroform and hydrogencarbonate are added.
An aqueous thorium solution was added. After filtering off the precipitate, the organic layer
After washing with water and drying over magnesium sulfate, the solvent is distilled off under reduced pressure.
did. The residue was subjected to silica gel column chromatography.
And a mixed solvent of chloroform: methanol = 97: 3.
Elution gave the desired product (100 mg).
[0219]1H-NMR (CDCl3: CD3OD =
9: 1, δ): 3.63 (2H, brt), 3.84
(3H, s), 4.32 (2H, brt), 4.72
(2H, s), 6.68 (1H, d, J = 9.0H)
z), 7.47 (1H, s), 7.50 (1H, d, J
= 9.0 Hz), 8.71 (1H, s)
[0218]
[Reference Example 43]4-[(2,4-diamino-6-pteridinyl) methyl
Ru] -3,4-dihydro-2H-1,4-benzoxa
Synthesis of gin-7-carboxylic acid
Reference Example 42. Compound (60 mg) in 1N
-Sodium hydroxide aqueous solution (20 ml) and methanol
(20 ml) in a mixed solvent and heated under reflux for 2.5 hours
did. After cooling, the solvent was distilled off, and water was added.
Adjusted to H = 5 (suspended). After leaving in a cool place overnight, filter
It was collected and dried to give the desired product (60.8 mg).
[0220]1H-NMR (DMSO-d6, Δ):
3.63 (2H, m), 4.22 (2H, m), 4.7
1 (2H, s), 7.21 (1H, s), 8.29 (1
H, s)
[0221]
Embodiment 23N- [4-[(2,4-diamino-6-pteridinyl)
Methyl] -3,4-dihydro-2H-1,4-benzoo
Xazin-7-carbonyl] -L-glutamic acid diethyl
Synthesis
Diphenyl phosphorocyanidate (64 μm)
l), triethylamine (60 μl), dry dimethyl
Reference Example 43 in a solution of Lumamide (5 ml). Compound of
(50 mg) and stirred at 80 ° C. for 5 minutes under a nitrogen atmosphere.
did. Cool to room temperature and triethylamine (20 μl)
And diethyl glutamate (34 mg) were added.
C. and stirred for 2.5 hours. After cooling, chloroform
Extracted with water and washed with aqueous sodium hydrogen carbonate and brine
did. After drying over magnesium sulfate, the solvent was distilled off. Remaining
The residue is subjected to silica gel column chromatography,
Elution with a mixed solvent of roform: methanol = 19: 1
Thus, the desired product (10 mg) was obtained.
[0223]1H-NMR (CDCl3: CD3OD =
9: 1, δ): 1.23 (3H, t, J = 6.8H)
z), 1.29 (3H, t, J = 6.8 Hz), 3.6
0 (2H, m), 4.11 (2H, q, J = 6.8H
z), 4.22 (2H, q, J = 6.8 Hz), 4.3
2 (2H, m), 4.71 (2H, s), 6,69 (1
H, d, J = 10.0 Hz), 7.29 (1H, d, J)
= 10.0 Hz), 7.36 (1H, z), 8.70
(1H, s)
[0224]
Embodiment 24N- [4-[(2,4-diamino-6-pteridinyl)
Methyl] -3,4-dihydro-2H-1,4-benzoo
Synthesis of Xazin-7-carbonyl] -L-glutamic acid
Embodiment 23 FIG. Compound (9 mg) in ethanol
(3 ml), and 1N aqueous solution of sodium hydroxide
The solution was added and stirred at room temperature for 4 days. The solvent is distilled off.
The column was subjected to Ricagel column chromatography.
Solvent: methanol: aqueous ammonia = 5: 4: 1 mixed solvent
Eluted, and collect the fraction containing the target substance,
The solvent was distilled off. Saturated aqueous sodium bicarbonate solution (20
0 μl), dissolve, add 1N-hydrochloric acid dropwise and adjust the pH.
Was adjusted to about 4 (suspended) and left in the cold overnight. Analysis
The product was collected by filtration and dried to obtain the desired product (2.8 mg).
[0226]1H-NMR (DMSO-d6, Δ):
1.86-1.95 (1H, m), 1.95-2.03
(1H, m), 2.24-2.38 (2H, m), 3.
67 (2H, t, J = 3.8 Hz), 4.25 (2H,
t, J = 3.8 Hz), 4.30 (1H, m), 4.7
0 (2H, s), 6.83 (1H, d, J = 8.6H)
z), 7.26 (1H, s), 7.30 (1H, d, J
= 8.6 Hz), 8.09 (1H, m), 8.70 (1
H, s)
IR (KBr) νmax 3464, 1642 and
1512cm-1
[0227]
【図面の簡単な説明】
図1は「P388細胞の増殖阻害作用」を、図2は「C
olon26の増殖阻害作用」を表わす。被験薬物のそ
れぞれの濃度における吸光度を、薬物非添加時の吸光度
を100%とした時の割合で示してある。BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 shows “P388 cell growth inhibitory action”, and FIG.
growth inhibition effect of olon26 ". The absorbance at each concentration of the test drug is shown as a percentage when the absorbance when no drug is added is 100%.
───────────────────────────────────────────────────── フロントページの続き (58)調査した分野(Int.Cl.7,DB名) C07D 475/08 REGISTRY(STN) CA(STN)──────────────────────────────────────────────────続 き Continued on the front page (58) Field surveyed (Int. Cl. 7 , DB name) C07D 475/08 REGISTRY (STN) CA (STN)
Claims (1)
S、CH2SO、CH2SO2およびCH2NHから成
る群より選ばれた一員を示し;R2は水素原子または炭
素数1乃至4の低級アルキル基を示し;nは1から4ま
での整数を示し;R3は一般式COOR4(ここでR4
は水素原子または炭素数1乃至4の低級アルキル基を示
す)または一般式NHCOR5(ここでR5は置換され
ていてもよいフェニル基を示す)または一般式CONR
6R7(ここでR6は水素原子または炭素数1乃至4の
低級アルキル基を示し;R7は炭素数1乃至4の低級ア
ルキル基または置換されていてもよいフェニル基を示
す)またはPO3H2、SO3Hで表される基を示す;
で表される化合物を有効成分として含有する制癌剤。(57) [Claims] General formula (I) Wherein R 1 is CH 2 , CH 2 CH 2 , CH 2 O, CH 2
R represents a member selected from the group consisting of S, CH 2 SO, CH 2 SO 2 and CH 2 NH; R 2 represents a hydrogen atom or a lower alkyl group having 1 to 4 carbon atoms; Represents an integer; R 3 is a general formula COOR 4 (where R 4
Represents a hydrogen atom or a lower alkyl group having 1 to 4 carbon atoms) or a general formula NHCOR 5 (where R 5 represents a phenyl group which may be substituted) or a general formula CONR
6 R 7 (where R 6 represents a hydrogen atom or a lower alkyl group having 1 to 4 carbon atoms; R 7 represents a lower alkyl group having 1 to 4 carbon atoms or an optionally substituted phenyl group) or PO A group represented by 3 H 2 or SO 3 H;
An anticancer agent comprising a compound represented by the formula (1) as an active ingredient:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP23755592A JP3387943B2 (en) | 1991-07-30 | 1992-07-22 | Anticancer drug |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP27904791 | 1991-07-30 | ||
| JP3-279047 | 1991-07-30 | ||
| JP23755592A JP3387943B2 (en) | 1991-07-30 | 1992-07-22 | Anticancer drug |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH05194231A JPH05194231A (en) | 1993-08-03 |
| JP3387943B2 true JP3387943B2 (en) | 2003-03-17 |
Family
ID=26533259
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP23755592A Expired - Fee Related JP3387943B2 (en) | 1991-07-30 | 1992-07-22 | Anticancer drug |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3387943B2 (en) |
-
1992
- 1992-07-22 JP JP23755592A patent/JP3387943B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH05194231A (en) | 1993-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5084468A (en) | Dc-88a derivatives | |
| JPH11505211A (en) | Biologically active peptides and compositions and uses thereof | |
| JPH10182583A (en) | New hydroxamic acid derivative | |
| JPH01226886A (en) | Pyrido (2, 3-d) pyrimidine derivative | |
| JPH01113389A (en) | Production of condensed pyridine compound | |
| CN111825700A (en) | Pyrazinothiazoles compound, application thereof and pharmaceutical composition containing pyrazinnothiazoles compound | |
| JPH02104587A (en) | N-(n-(tetrahydropyrride (2, 3-d) pyrimidinylmethyl) aminomethylbenzoyl)glutamic acid derivative | |
| US5905076A (en) | 6-substituted amino-4-oxa-1-azabicyclo 3,2,0! heptan-7-one derivatives as cysteine protease inhibitors | |
| JPH03505205A (en) | Condensed pyrazole 3-oxo-propanenitrile derivative and method for producing the same | |
| AU594163B2 (en) | 4(3h)-oxo-5,6,7,8-tetrahydropyrido-(2,3-d)pyrimidine derivatives | |
| JP2818198B2 (en) | N- (5,6,7,8-tetrahydropyrido [2,3-d] pyrimidin-6-ylalkanoyl) glutamic acid derivative | |
| JPH03505204A (en) | Tricyclic 3-oxo-propanenitrile derivative and method for its preparation | |
| KR100192999B1 (en) | Novel carbamoyl derivatives, the process of preparaing them and pharmaceutical compounds containing them | |
| JP3387943B2 (en) | Anticancer drug | |
| EP0543997B1 (en) | Derivatives of methotrexate with antirheumatic activity | |
| FR2483929A1 (en) | NOVEL N6-SUBSTITUTED ADENOSINS USEFUL AS ANTIHYPERTENSIVE DRUGS, THERAPEUTIC COMPOSITIONS AND PHARMACEUTICAL FORMS CONTAINING THEM, AND PROCESS FOR THE PREPARATION THEREOF | |
| JP3281099B2 (en) | Anti-rheumatic drug | |
| JP3100469B2 (en) | Psoriasis treatment | |
| JPH08301831A (en) | Stilbene derivative and carcinostatic agent containing the same | |
| JPH0920738A (en) | Nitric ester obtained from derivative of 2-(2,6-dihalophenylamino)phenylacetoxyacetic acid and its production | |
| WO1994014810A1 (en) | Methotrexate derivative | |
| US5281708A (en) | 9-Substituted-8-halo or -8-hydroxy-9-deazaguanines as inhibitors of PNP | |
| Sajadi et al. | Antitumor and antiinflammatory agents: N-benzoyl-protected cyanomethyl esters of amino acids | |
| JPH07278080A (en) | Alanylalaninol derivative | |
| JP3124592B2 (en) | New methotrexate derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |